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1 Introduction and aims 
Guinea pigs (Cavia porcellus, GPs) have been used as an animal model for over 200 years and they 
continue to be used in the research fields of infectious diseases, allergy, respiration, nervous and 
immune systems and auditory studies. They are also frequently kept as companion animals and 
are therefore seen in veterinary practice. In both research and clinical practice, anaesthesia is fre-
quently required. In the clinical routine, GPs are anaesthetized for surgeries and to perform imag-
ing procedures. In the laboratory environment, anaesthesia is required for substance application, 
device implantation or blood sampling. Anaesthesia research is still needed in GPs, as anaesthesia 
is known to alter physiological responses. Especially anaesthesia in GPs has been associated with 
a high mortality risk (1). Knowledge and correct interpretation of the anaesthetic’s influences are 
essential. In practice, this knowledge can save the animal's life, and in laboratory medicine the 
knowledge about the effects of the anaesthetics is necessary in order to interpret study results 
correctly. Based on recent literature, 3 anaesthesia options have often been used in the GP: the 
injectable combination of ketamine and xylazine (KX), the fully antagonizable combination of me-
detomidine, midazolam and fentanyl (MMF) and the volatile anaesthetic isoflurane (Iso). 
 
There have been reports on the influence of anaesthesia on cardiovascular parameters in GPs (2), 
but none of these studies has been performed using radiotelemetry technology. This gold stand-
ard technique provides many advantages, especially for the critical anaesthesia at the GP. Arterial 
blood pressure (BP), heart rate (HR) and core body temperature (BT) can be collected continuously 
without human intervention, such that the critical induction and recovery periods of anaesthesia 
can be monitored without interruption. The effects of the anaesthetics can be monitored live on 
an external monitor, whereby one can respond immediately in the case of an emergency. Baseline 
and long-term recovery values can also be acquired without disturbing the animal and therefore 
represent more physiological parameters as compared to parameters acquired manually. The 
radiotelemetry technology is the only method which allows the repeated investigation of BP in the 
same animal, as the alternative is direct blood pressure cannulation which only provides reliable 
results for up to one week (3). Therefore, if the BP is of long-term interest, using radiotelemetry 
reduces the animal number (3R value (3)). 
The aim of this research was to investigate to what extent anaesthesia influences hemodynamics, 
core body temperature and other anaesthesia relevant parameters in the GP. For this purpose, 
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radio telemetry transmitters were implanted abdominally into GPs. Thereafter, two studies were 
carried out with the successfully implanted animals. The first experiment tested the effects of one-
time anaesthesia with either MMF, KX or Iso and the second investigated the influence of 6 regu-
larly repeated anaesthesias over 3 weeks. The implantation approach of the radiotelemetry device 
for measuring arterial BP and BT in the GP is theoretically the same as in rats (4), but its perfor-
mance in GPs is more challenging with high failure rates. As our optimised approach resulted in 
high long-term survival rates and many of the refinements can also be applied to other surgical 
procedures, these findings were also published and included in this manuscript. 
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2 Anaesthesia in the GP 
2.1 Anaesthesia - definition and aims 
General anaesthesia is defined as an anaesthetic-induced reversible state of unconsciousness 
(hypnosis), skeletal muscle relaxation (immobilisation) and analgesia (5). So far, no single anaes-
thetic can provide all the criteria mentioned above, therefore anaesthetics from different sub-
stance classes need to be combined. General anaesthesia can be achieved by injection or inhala-
tion anaesthesia and both should meet the following criteria: 
 Good adjustability 
 Reliable effect 
 Large safety margin 
 Quick induction and recovery 
 Stress-free application for both animal and anaesthetist 
 Low impact on physiological parameters (HR, BP, respiratory rate, metabolism) 
Good adjustability (a targeted, predictable change of the anaesthetic status and mainly of the nar-
cotic depth) and a quick recovery enable a fast return to self-regulation of physiological functions 
(BP, HR, BT) and spontaneous behaviours (food and water intake, social contact, movement) (6). 
The post-anaesthetic energy and water consumption and the ability to counterbalance the tem-
perature losses during anaesthesia are especially important for a full recovery. Applying an anaes-
thetic, preferably with little stress, should also reliably lead to anaesthesia that is safe for user and 
animal. The requirements for anaesthesia in the laboratory in experimental procedures differ from 
those in veterinary practice, as stable hemodynamic parameters are of primary concern in the 
animal model during an experiment, whereas the animals in veterinary practice are there for ther-
apeutic purposes with a need for a reliable and safe anaesthesia. Examples for the purposes of 
anaesthetizing GPs are: 
 Immobilisation (blood collection from the jugular vein (7), imaging techniques) 
 Procedures (castration, radiotelemetry transmitter implantation) 
 Therapeutic procedures (fracture treatment (8), dental procedures) 
The anaesthesia and analgesia protocol must be tailored to the procedure’s needs and the level 
of anaesthesia required. However, the choices available for anaesthesia of small mammals are 
limited, as the combinations used to interfere with the experimental procedures and results or 
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because of obstacles with drug availability or national drug regulations with specific substances 
(6).  
 
2.2  GP anaesthesia – a challenge 
Small mammal anaesthesia has a higher risk of mortality compared to cats and dogs (9). Both 
inhalation and injection approaches have been used in GPs, but especially KX led up to 30 % mor-
tality and therefore the GP is considered a high-risk patient (10,11). Even with modern anaesthet-
ics, the anaesthetic/sedative-related death rate in GPs is still at 3.8 % (9).  
Challenges with GP anaesthesia begin with determining an accurate body weight which can vary 
up to 20-40 % depending on the individual’s gastrointestinal filling resulting in dosing inaccuracies. 
Fasting the GPs prior to anaesthesia, on the other hand, leads to hypoglycaemia. Administration 
routes are limited as GPs have few accessible peripheral vessels, none of which are practicable for 
conscious intravenous applications, ruling out short-acting hypnotics like propofol. Therefore, for 
injection anaesthesia, extravasal administration routes (intraperitoneal, intramuscular or subcu-
taneous) are used which are associated with a slower onset of effect and require small total vol-
umes to avoid tissue irritation. The HR is too fast to be counted with a stethoscope, therefore GP 
anaesthesia needs special equipment like a high-frequency pulse oximeter for reliable monitoring 
during the narcosis. 
The relatively large body surface to body volume ratio makes GPs prone to anaesthesia related 
hypothermia which results in prolonged recovery times or even death (11). GPs are very sensitive 
to all volatile anaesthetics, leading to mucous membrane aggravation, strong salivation and tear 
production (12), often resulting in impaired breathing. Intubation is also inadvisable, as food par-
ticles in the mouth can be inadvertently pushed into the lung with consequent pneumonia (13). 
Animal technicians and veterinarians are in many cases not specifically educated and the incon-
spicuous symptoms of ill GPs are therefore often not detected. As a result, many patients are 
presented with severe diseases that would have been unproblematic, had they been detected in 
an earlier stage. A successful anaesthesia in GPs, therefore, requires a detailed knowledge of their 
species-specific requirements, a careful selection of the best anaesthesia for a given procedure 
and having the needed equipment to adequately perform the anaesthesia and to monitor physio-
logical status both during anaesthesia and recovery.  
2.3 The GP in research  
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2.3 The GP in research 
GPs were among the first animals widely used in research laboratories and their first description 
as an animal model was in 1881, when Robert Koch used 2 GPs to discover Mycobacterium tuber-
culosis. In the early 1900s, they were used to discover the passive immunisation against tetanus 
and diphtheria (14). In 1907, the Norwegian professor Holst und the physician Frölich were able to 
induce scurvy in GPs due to their dietary vitamin C dependency (15). Since then, they have been 
used in multiple research fields, thereby aiding the discovery of adrenaline, antibiotics, the inves-
tigation of blood transfusion and the replacement of heart valves. Their popularity for the use in 
studies even led to the term „guinea pig“ in the meaning of the German “Versuchskaninchen”. 
Nowadays, GPs are regularly used in the field of preclinical safety pharmacology, either in an 
anaesthetised state e.g. for cardiac electrophysiological effect measurements (16) and for evalu-
ation of cardiac safety of drug candidates (17) or in the awake state for the study of electrocardi-
ogram variables (18,19). Further research areas include the investigation of the respiratory, audi-
tory and immune systems and allergy and nutritional research (7). The Bundesministerium für 
Ernährung und Landwirtschaft (BMEL) publishes annual numbers of animals used in research in 
Germany (Table 1). Matching the BMELs aim to decrease the animal number used for research 
purposes, the number of GPs used in animal experiments is steadily declining. 
 
Table 1: (20,21). Bars represent the total numbers of GPs; the trend line represents the course of 
the percentage share of GPs among all animals used in research. 
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2.4  Reflexes and evaluation of narcotic depth 
The determination of the narcotic depth is the decision criterion on which an operable state is 
established. It must be checked before every painful procedure which is done by means of the 
evaluating the reflex responses. Reports and references for the evaluation of reflexes during the 
anaesthesia in the GP vary widely. Literature reports range from stating only the anaesthetic and 
dosage, over naming a reflex without defining the testing method or the thereof derived interpre-
tation (8,22), to detailed reports about the performed test and the deduced anaesthesia state 
(10,11). The correct interpretation of a given reflex response in GPs is admittedly challenging. It 
requires experience, as the response and the significance vary in the GP (1) depending on such 
factors as: 
 Used narcotic (ketamine induces catalepsy) 
 Reflex test performance (intensity, repetition, changing performers) 
 Individual condition (BT, illness) 
Interpreting multiple test results is, therefore, necessary (23). The first relevant time point during 
anaesthesia is from when on the animal is immobilised. The second is the onset of surgical toler-
ance. The hypnosis state (III1), preceding the surgical tolerance, provides unconsciousness and 
good muscle relaxation but no analgesia. Pain stimuli in this state can range from heart and res-
piratory rate increases as far as neurogenic shock (24). Only the surgical tolerance stadium (III2) 
provides a strong analgesia. Table 2 shows which tests were described by whom which plane of 
anaesthesia was tested and in which phase this test was relevant.  
2.4  Reflexes and evaluation of narcotic depth  
8 
 
Performed tests Tested plane Relevant phase Reference 
Righting reflex 
Immobiliza-
tion 
II ↔ III1 
Radde, et al. (25)  
Buchanan, et al. (26)  
Seidensticker (10)  
Sloan, et al. (27)  
Corneal reflex 
Spontane-
ous reflex 
arc 
III1 ↔ III2 
Heide (11)  
Seidensticker (10)  
Lid reflex 
Spontane-
ous reflex 
arc 
III1 ↔ III2 
Radde, et al. (25)  
Heide (11)  
Seidensticker (10)  
Sloan, et al. (27)  
Ear reflex 
(Touching of the outer 
ear canal with the tip 
of a clamp) 
Spontane-
ous reflex 
arc 
III1 ↔ III2 
Radde, et al. (25)  
Buchanan, et al. (26)  
Heide (11)  
Seidensticker (10)  
Jaw muscle tone anaesthesia III1 ↔ III2 Radde, et al. (25)  
Hind leg muscle tone anaesthesia III1 ↔ III2 
Radde, et al. (25)  
Seidensticker (10)  
Ear pinch on the pinna 
with a mosquito clamp 
analgesia No reaction ≙ III2 Buchanan, et al. (26) 
Needle/clamp/finger 
pinching of the 
interdigital skin/foot 
pad on the hind leg 
analgesia 
III2 
(28): “too deep” when the 
response was completely 
abolished (that was accom-
panied by severe respiratory 
depression and cyanosis) 
Radde, et al. (25)  
Jacobson (29)  
Heide (11)  
Seidensticker (10)  
Schwenke, et al. (28)  
mosquito clamp pinch-
ing of the interdigital 
skin on the front leg 
analgesia No reaction ≙ III2-III3 
Heide (11)  
Seidensticker (10)  
Inguinal reflex (IG) 
(pinching of the ingui-
nal skin until the 1st 
ratchet of an artery 
clamp) 
analgesia No reaction ≙ III2 Seidensticker (10)  
Respiration rate  
CNS depres-
sion 
 Schwenke, et al. (28)  
mucous membrane 
colour 
perfusion  Schwenke, et al. (28)  
Noise sensibility 
CNS depres-
sion 
 Seidensticker (10)  
Table 2: Performed reflex test, the tested plane, for which phase is it relevant and who described 
it. Anaesthesia phases (24) II= excitation, III1= hypnosis, III2= surgical tolerance, III3 = depression. 
 
The authors agree that the righting reflex (RR) is the relevant test for the time of immobilization. 
Thus, a negative RR marks the beginning of induction and the transition from the wake-up to the 
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recovery period. Before the entrance of surgical tolerance (III2), analgesia cannot be expected. 
Therefore, the performed reflex tests on the ear, lid or cornea do not screen for analgesia, but 
rather provide the anaesthetist with valuable feedback on the narcosis depth on the way to surgi-
cal tolerance. Pain-inducing tests only become relevant, when it comes to the differentiation be-
tween stage III1 and III2. Table 2 shows that the analgesic tests, determining surgical tolerance, are 
performed on 2 sites, the pinna of the ear and the extremities. There the skin is pinched with the 
fingers, a clamp or a needle. The desired answer to confirm the surgical tolerance is a very mild or 
no reaction (24).
2.5  Injectable anaesthetics  
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2.5  Injectable anaesthetics 
A combination of various injectable anaesthetics may be used in GPs depending on  
 their utilisation in clinical veterinary practice or the laboratory environment 
 the required anaesthesia depth and duration  
 the degree of analgesia required 
 if the GP is intended to awake from the anaesthesia. 
The choice of anaesthesia for use in research protocols is made with a focus on a reliable induction 
and stable maintenance, a low influence on physiological parameters and a high safety for the 
user. Ideally, the method should also support a study design in which multiple animals can be kept 
under anaesthesia simultaneously.  
Given these requirements, anaesthetics like urethane (22), pentobarbital (2) or the combination 
of fentanyl/droperidol/urethane (30) have been used for terminal, long-term studies. These agents 
were not utilised in veterinary practice due to their disadvantageous side effects like urethane’s 
carcinogenic effect or the very long immobilisation after pentobarbital-induced anaesthesia (294 
min, (31)). The following combinations are also described in the literature, but they are not mar-
keted in Germany which limits their use.  
 Hypnorm® is a neuroleptic-analgesic combination of fentanyl and fluanisone. If used alone, 
the analgesia provided is not adequate and, even when used together with a benzodiaze-
pine (midazolam/diazepam), the depth of anaesthesia fluctuates markedly (32). 
 Tiletamine/Zolazepam is a combined preparation of a dissociative anaesthetic with longer 
action than ketamine and a benzodiazepine to counter-balance the muscle tension. In GPs, 
it was used alone, with an α2-adrenoceptor agonist or with α2-adrenoceptor agonist + bu-
torphanol (29). 
o Tiletamine/Zolazepam was tested in dosages from 10-100 mg/kg in GPs, but it did not 
produce satisfactory analgesia. It may be used for short periods of restraint but it is not 
suitable for painful procedures (25). Buchanan, et al.(26) tested tiletamine/ zolazepam 
40 mg/kg with the addition of 3 α2-adrenoceptor agonists xylazine (5mg/kg), medetomi-
dine (0.5mg/kg) or detomidine (5 mg/kg). They were able to perform ovariohysterectomy 
in 14 of 30 GPs with the addition of xylazine and in 23 of 29 GPs with medetomidine, 
whereas no GP lost the ear pinch response when tiletamine/zolazepam was administered 
2.5  Injectable anaesthetics  
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together with detomidine. They concluded that the combination with medetomidine pro-
duced a relatively reliable anaesthesia for major surgical procedures which lasted be-
tween 168 and 230 min. 
o Jacobson (29) studied tiletamine/zolazepam (50/50 mg/mL, 60 mg/kg body weight) with 
the addition of xylazine (5 mg/kg) and butorphanol (0.1mg/kg) for deep, long-duration 
analgesia and rapid recovery with minimal effects on physiological parameters.  
o Butorphanol was added to improve the anaesthetic effect because he observed BP ef-
fects to the toe pinching test in preliminary anaesthesias with only xylazine. He reports a 
gentle induction and recovery, long immobilisation (149 min) and surgical tolerance 
within 10 min in all animals. Deep surgical anaesthesia lasted for 66 min with an additional 
43 min on a moderate plane. The cardiovascular system was moderately depressed which 
was manageable, however, there were substantial effects on respiratory function and 
blood gas parameters. In summary, the anaesthesia required adjustments to improve the 
respiratory and blood gas effects and the immobilisation duration. 
o Saffan is an alfaxalone-alphadolone mixture which was tested intravenously after induc-
tion with halothane. Schwenke, et al. (28) report that the transfer to saffan was critical 
and often accompanied with respiratory arrest and the need for resuscitation. It provided 
adequate anaesthesia but only when administered close to the lethal dose. Adjusting the 
correct infusion rate was difficult due to the narrow therapeutic index; therefore, the 
anaesthesia fluctuated between light and deep. 
In contrast to the requirements for experimental procedures, veterinary practitioners focus on 
different criteria. The adaptability of the narcosis depth is particularly relevant because the ani-
mals should only have post-anaesthetic sleep and should return quickly to self-regulation. Further-
more, the safety for animals and users and the long-term effects on the patients are of great rel-
evance. The substances used to fulfil these goals, are described in the following sections.  
2.5.1 α2-adrenoceptor agonists 
Alpha2-adrenoceptor agonists are used as analgesic sedatives in veterinary practice and are addi-
tionally valued for potentiating the effects of other anaesthetics when used in combinations.  
For anaesthesia in the GP, xylazine, medetomidine and recently also dexmedetomidine (the active 
isomer of medetomidine) are used.   
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Alpha2-adrenoceptor agonists mimic the effects of the sympathetic nervous system by binding to 
α2-adrenoceptors which constitute a family of G-protein–coupled receptors. In the central nerv-
ous system (CNS), α2-adrenoceptors may exist presynaptically, postsynaptically, or both. Blockade 
of α2-adrenoceptors, especially presynaptic ones in noradrenergic neurons, promotes the release 
of norepinephrine. The adrenoceptor subtypes α2A to α2D have been found in the brain (33). They 
have been isolated centrally (subtype α2A: concentrated in the locus ceruleous, α2B-receptors: only 
in the thalamus, α2C: mainly in the basal ganglia, hippocampus and cerebral cortex) and in the spi-
nal cord (α2A-receptors: mainly on central terminals of nociceptive primary afferent nerve fibres 
and in the dorsal horn or lateral spinal nucleus, α2C-receptors: axonal endings on excitatory inter-
neurons) (34).  
Alpha2-adrenoceptor agonists induce a dose-dependent sedation. Once the maximal sedative ef-
fect is reached, further increases in dose result only in a prolonged, but not deeper sedation (ceil-
ing effect). A deeper level of anaesthesia and analgesia can be achieved by combining α2-adreno-
ceptor agonist and opioids. Their receptors are located in the same brain regions and even on the 
same neurones and can, therefore, activate the same signal transduction systems. Alpha2-adreno-
ceptor agonists provide a robust muscle relaxation which can counterbalance the catalepsy in-
duced by ketamine. Concerning the cardiovascular system, α2-adrenoceptor agonists initially lead 
to hypertension by causing a peripheral vasoconstriction which is then followed by a centrally me-
diated vasodilation leading to hypotension. With agents like xylazine that have a low α2-selectivity, 
the transient hypertension is short and the hypotension long, whereas medetomidine causes a 
relatively long hypertension (35). With all α2-adrenoceptor agonists, the HR is distinctly depressed 
and especially xylazine is known to cause bradyarrhythmias. The central thermoregulation is de-
pressed by α2-agonists and the lack of muscle activity during anaesthesia rapidly leads to hypo-
thermia. The respiratory rate is lowered centrally but the breathing volume is increased, such that 
with medetomidine high doses or addition of opioids can result in substantial respiratory depres-
sion (36). Side effects of α2-adrenoceptor agonists are polyuria, reduced pancreatic insulin pro-
duction with progressive hyperglycaemia and a gastrointestinal motility decrease (37). 
The individual reactions to α2-adrenoceptor agonists differ greatly, depending on the animal’s ag-
itation level (36), on the density and location of the α-adrenoceptors and the agent’s α2: α1 recep-
tor selectivity (38).  
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Strongly α2-selective agonists are preferred, because activation of α1-adrenoceptors is associated 
with undesirable effects including arousal, restlessness and enhanced movement. Some of the α2-
adrenoceptor agonists activate the imidazoline receptor in the medulla oblongata (Table 3) and 
that may play an important role for the hypotensive effect (35) observed after α2-adrenoceptor 
agonists administration. 
Table 3: Alpha2-adrenoceptor agonists used in the GP, their receptor selectivity and their imidaz-
oline activity. 
Mechanism of action 
Alpha2-adrenoceptor agonists inhibit the presynaptic influx of calcium and neurotransmitters like 
dopamine and norepinephrine in the CNS. The resultant sedation is mediated in the brainstem 
and pons by the reduction of norepinephrine release which is needed for arousal. Stress, pain, 
fear or excitement can interfere with this mechanism, as they increase excitatory endogenous 
catecholamines (38). The induced analgesia results from interaction with multiple sites in the pain 
pathway. Alpha2-adrenoceptors in the dorsal horn of the spinal cord are targeted directly and 
transport the nociceptive signals to the brainstem where they are modulated. Bradycardia devel-
ops because the outflow of norepinephrine is reduced and decreased sympathetic tone together 
with the peripheral vasoconstriction causing an increase in systemic vascular resistance. The inhi-
bition at the interneural level of the spinal cord results in the muscle relaxation. Diuresis is caused 
by the reduction of antidiuretic hormone and an increased glomerular filtration due to initial hy-
pertension. 
Pharmacokinetics 
Xylazine and medetomidine are rapidly absorbed after i.m. injection. Peak plasma levels of me-
detomidine are reached 10 min after s.c. administration in the rat (37). Xylazine and medetomi-
dine are biotransformed in the liver via aliphatic hydroxylation and oxidation and their inactive 
metabolites are excreted mainly in the urine and, to a small extent, with the faeces (species spe-
cific) (5,39). 
 Compound α2: α1 receptor selectivity I2 – Imidazoline activity 
Agonists Xylazine 160 No 
Detomidine 260 Yes 
Medetomidine 
Dexmedetomidine 
1620 Yes 
Yes 
2.5  Injectable anaesthetics  
14 
 
Field of application 
Alpha2-adrenoceptor agonists are applied in both experimental and clinical settings and are used 
for sedation (0.15mg/kg i.m., Erhardt, et al. (13) and more commonly for general anaesthesia in 
the GP as they can be combined easily with opioids or with ketamine. In Germany, xylazine (20 
mg/mL) and medetomidine (1.0mg/mL) are only approved for use in dogs and cats and therefore 
need to be used “off-label” for GPs. Owing to its side effects, α 2-adrenoceptor agonists should not 
be used in patients with cardiovascular, kidney or liver disease (5).  
2.5.2 Atipamezole 
Atipamezole is an α2-adrenoceptor antagonist and rapidly and effectively reverses all effects of 
the α2-adrenoceptor agonists. It is highly selective for all α2 subtypes (α2/α1, 8526:1 receptor se-
lectivity, (33)) and is therefore preferred over yohimbine. In Germany, it is only sold for the intra-
muscular use in dogs and cats in a 5mg/mL concentration. 
Mechanism of action 
Atipamezole blocks the central and peripheral α2-adrenoceptors, thereby preventing their excita-
tion. 
Pharmacological effect 
Atipamezole increases the central noradrenaline and serotonin turnover, clinically visible in ex-
citement and agitation, a transient hypotension and tachycardia (34).  
Pharmacokinetics 
Atipamezole may be applied para- or intravenously, but apart from emergencies, s.c. or i.m. ad-
ministration should be used to achieve a slower onset of effect. After s.c. administration, it is rap-
idly absorbed and distributed. Medetomidine can be reversed within 3-7 min when using a 4-6 
fold dose of atipamezole. Its half-life is twice as long as that for medetomidine, usually keeping 
the patient from becoming re-sedated (38). The LD50 is > 30mg/kg after i.v., s.c. or i.p. injection 
in mice and rats. The elimination half-life is 1.3 h after a single s.c. dose in the rat and it undergoes 
an extensive first-pass effect in the liver where it is also metabolised (34).  
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Field of application 
In GP anaesthesia, atipamezole is the antagonist of choice for the reversal of α2-adrenoceptor 
agonists. Therefore, it is used for partial antagonisation of KX and it is an indispensable part of the 
MMF antagonisation. 
2.5.3 Midazolam  
Midazolam is a benzodiazepine with anticonvulsant, anxiolytic and mildly sedative properties and 
may be competitively antagonised with flumazenil or sarmazenil (distributed in Switzerland). Ben-
zodiazepines act on the GABAA-receptors which are found mainly in the cerebral cortex, hypothal-
amus, thalamus, limbic system and to a lesser extent in the periphery. This primarily CNS receptor 
distribution also explains their lack of effect on the circulation and respiration in therapeutic doses 
(40), however, benzodiazepines may potentiate the respiratory depressive effect of other agents. 
Unlike diazepam, midazolam is water soluble and can, therefore, be administered in combination 
with other drugs in a single syringe, as used with MMF (41).  
Mechanism of action 
Benzodiazepines bind to the GABAA-receptor, a large macromolecule with multiple binding sites 
which enable synergistic effects with e.g. opioids (40). This binding opens the GABA-activated chlo-
ride channels and enables the inflow of chloride ions, thus negatively charging the neurone and 
making it resistant to excitation. This results in the muscle relaxing, sedative and anxiolytic effect. 
Different subunits on the GABAA receptor are likely responsible for these different effects, with 
the α2 subunit probably causing the anxiolytic effect. Activation of GABA receptors in the motor 
neurones and dorsal horn of the spinal cord probably mediate the muscle relaxing effects. 
Pharmacokinetics 
Due to its good aqueous solubility and therefore the lack of irritating solvents, intra and extra 
venous (s.c., i.m., i.p.) injection is possible. There is a high bioavailability of around 90 % after i.m. 
administration. Midazolam is metabolised through α-hydroxylation by cytochrome P450 in the 
liver into an inactive metabolite which is excreted mainly in the urine (42).  
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Field of application 
Midazolam has been used for sedation (2.5 – 5.0 mg/kg i.m. (13)) but the degree of sedation varies 
individually and the duration of sedation often does not suffice for an adequate treatment. There-
fore, in GPs, it is mostly used in combination with fentanyl and α2-adrenoceptor agonists within 
the fully antagonisable anaesthesia (VAA/MMF).  
2.5.4 Flumazenil 
Flumazenil is a selective benzodiazepine antagonist which can reverse their effects within 1-2 min 
after i.v. injection by competitively blocking the benzodiazepine binding site on the GABAA-recep-
tor. Depending on the action duration of the used benzodiazepine, additional flumazenil dosing 
might be required due to its short plasma half-life time.  
As the intrinsic activity on the benzodiazepine site is very low, the administration of flumazenil 
does not induce clinical effects by itself (43). In Germany, it is not marketed for veterinary use and 
therefore requires an “off-label” use for GPs. 
Field of application 
Flumazenil is mainly used in GPs for the antagonisation of midazolam in the MMF anaesthesia and, 
in rarer cases, after benzodiazepine overdosing or to end the sedation. However, the antagonisa-
tion of the benzodiazepine in MMF may be omitted (10) which is commonly done because of its 
high price (255€/ 100 mL, August 2016).  
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2.5.5 Fentanyl  
Fentanyl is a synthetic and selective μ-opioid-receptor analgesic which is approximately 100 times 
more potent and 1000 times more lipophilic than morphine (35,44). Since 2012 it is distributed 
for animal use in Germany as fentanyl citrate 50μg for dogs and it underlies the strict regulations 
for narcotic drugs. Fentanyl may be antagonised with naloxone. 
Mechanism of action 
Fentanyl selectively acts on μ-opioid receptors in the CNS and in the periphery. Depending on the 
receptor subtype, different agonistic actions are mediated (Table 4). 
Opioid receptor Agonistic action Drug 
μ1 
analgesia (mainly supraspinal), respiratory 
depression, low addiction risk, bradycardia, 
hypothermia, peripheral vasodilation, mio-
sis 
morphine, fentanyl, levo-
methadone, buprenorphine, 
butorphanol, naloxone 
μ2 
Analgesia (spinal), respiratory depression, 
high addiction risk 
Table 4: (35). Opioid receptors, their agonistic action and the drugs that act on the μ-opioid re-
ceptors. 
Pharmacological effect 
Fentanyl has a short duration of action (20-30 min) (35). This comes with the benefit of quick 
adjustability, but it is simultaneously unsuitable for long-term anaesthesia. Extravenous and ve-
nous administration routes can be chosen. The most relevant side effect in the GP is respiratory 
depression. Research shows that low opioid doses influence the production of the breathing 
rhythm and pattern and that higher doses decrease the tidal volume (45). 
Pharmacokinetics 
Fentanyl is quickly metabolised in the liver and excreted in the urine and bile. 
Field of application 
Fentanyl is usually not utilised in GPs for analgesia, however, it may be administered during very 
painful surgeries as an intraoperative bolus injection (0.05-0.1 mg/kg). Its bradycardic side effect 
may be used to evaluate the degree of analgesia. The most common application is as an analgesic 
component in the MMF anaesthesia. 
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2.5.6 Naloxone 
Naloxone is a pure opiate antagonist without agonistic properties (35) and a high safety margin. It 
reverses all pharmacological effects from exogenous and endogenous opioids. Attention must be 
paid to the post-anaesthetic pain management, as it antagonises not only the respiratory and 
bradycardic side effects of opioids, but also the analgesia. Therefore, an adequate analgesic cov-
erage with a non-opiate needs to be ensured ahead of time.  
Mechanism of action 
Naloxone competitively binds to the opioid receptors with the highest affinity to μ-opioid recep-
tors. It can be displaced reversibly from the binding site by addition of an opioid agonist. Substan-
tially higher doses of naloxone are needed for the reversal of the partial opioid agonist buprenor-
phine (43).  
Pharmacokinetics  
Reports on the half-life of naloxone vary greatly (43) and depend on the administration route. 
Rebound-effects after opioid use have been described which can be reversed with additional 
doses of naloxone (0.003-0.03 mg/kg i.m. or s.c. (46)). Naloxone is mainly excreted via glucuroni-
dation in the liver and excreted in the urine. 
Field of application 
Naloxone is presently only marketed for human use in Germany. In GP anaesthesia, it is used for 
the antagonisation of the MMF anaesthesia. It may also be used in emergencies to reverse respir-
atory depression after opioid administration with a dose of 0.01-0.1 mg/kg (47); it should be ad-
ministered using the quickest route. 
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2.5.7  Fully antagonisable anaesthesia (VAA or MMF) 
The anaesthesia consisting of opioid, benzodiazepine and α2-adrenoceptor agonist is a relatively 
new combination anaesthesia which holds the unique benefit of antagonisability of all compo-
nents. Thus, the MMF anaesthesia can now be terminated similarly fast as it is possible with Iso 
anaesthesia. The MMF anaesthesia has also been applied in many other small mammals in addi-
tion to the GP (rat, mouse, gerbil, chinchilla, hamster (5)). The 3 components are easily combined 
and they potentiate their equal effects, like the analgesia in α2-adrenoceptors activation and opi-
oids. That provides the benefit of no or reduced side effects due to the smaller doses required.  
Roberts (48) described a fully antagonisable anaesthesia with the i.m. administered agents fenta-
nyl (0.05mg/kg), climazolam (2.0 mg/kg) and xylazine (2.0 mg/kg). She stated a good surgical tol-
erance for approximately 45 min in GPs. The negative effects on respiration, HR and circulation 
were completely reversed within 2 min after i.v. antagonisation using naloxone (0.03 mg/kg), sar-
mazenil (0.3 mg/kg) and yohimbine (2.0 mg/kg). 
Henke (1) refined the combination by using midazolam (1.0mg/kg) instead of climazolam, as this 
benzodiazepine is commercially available in Germany and soluble in water in contrast to diazepam. 
Replacing xylazine with medetomidine (0.2 mg/kg) and its substantially higher α2-adrenoceptor 
selectivity reduced the α1-adrenoceptor mediated effects of peripheral vasoconstriction and led 
to a predictable and effective sedation and analgesia. The antagonist combination was also im-
proved with the benzodiazepine antagonist flumazenil (0.1 mg/kg) and the α2-adrenoceptor an-
tagonist atipamezole (1 mg/kg). The following Table 5 lists the currently recommended doses for 
the agonist and antagonist mixtures in GPs. 
Purpose Product name 
agonists Intramuscular injection (i.m.) in mixed syringe  
MMF =  
1. Medetomidine 0,2 mg/kg + 
2. Midazolam       1,0 mg/kg +  
3. Fentanyl            0,025 mg/kg 
antagonists Subcutaneous injection (s.c.) in mixed syringe  
AFN =  
4. Atipamezole 1,0 mg/kg + 
5. Flumazenil    0,1 mg/kg +  
6. Naloxone      0,03 mg/kg 
Table 5: Medetomidine-
midazolam-fentanyl an-
aesthesia agonist and 
antagonist dosages for 
the use in GPs (13). 
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Seidensticker (10) studied this combination, also known as “triple anaesthesia“ in 51 GPs in clinical 
practice and antagonised the animals either fully or partially, namely with or without the benzo-
diazepine antagonist, here sarmazenil. The fully antagonised GPs regained their RR approximately 
5 min earlier and displayed atipamezole related temporary restlessness, whereas some animals in 
the partially antagonised group displayed a lingering midazolam sedation.  
Pros and Cons 
The benefits of the MMF anaesthesia include a low-stress induction, as the triple combination 
does not require a premedication. The GP needs to be injected once or twice, depending if the 
total injection volume exceeds the amount suitable for a single injection site. The loss of righting 
is achieved within 3.5 min and they are surgically tolerant after 10 min after induction. During the 
anaesthesia, the fentanyl provides good analgesia coverage. The surgical tolerance can be main-
tained for at least 40 min and the duration can be easily extended if needed by injecting one-third 
of the initial dose. For reversal, the AFN mixture is injected s.c. and the GP will regain a reliable RR 
within 3-7 min. Injection anaesthesia facilitates transport or repositioning of the animal if needed, 
compared to inhalation anaesthesia, nevertheless, supplemental oxygen and warmth must be 
available. A disadvantage of the MMF is the time required until both mixtures are prepared and 
the necessity to store 6 substances simultaneously. The relatively large dose volume needs to be 
divided into two injections if the volume exceeds 0.5 mL with the drawback of having 2 injections 
(1). Additionally, fentanyl is regulated by narcotic drug guidelines and flumazenil is expensive. The 
latter may be omitted without great disadvantages, depending on the patient (10). The disad-
vantage of the analgesic antagonisation can be balanced easily by applying metamizole or NSAIDS 
at the beginning of a painful procedure. For procedures inducing longer or substantial pain, nalox-
one antagonisation may also be omitted (6). 
Field of application 
This anaesthesia can be used by both clinicians and researchers, but it has not yet been described 
in laboratory GP studies, maybe because MMF literature published in English is limited. With the 
exception of cases needing only very short narcosis or multiple anaesthesias per day, MMF has 
become the gold standard in Germany for a variety of procedures requiring anaesthesia in GPs, 
like castration (49). 
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2.5.8 Ketamine  
Ketamine induces a state of “dissociative anaesthesia”, meaning a functional splitting between 
thalamo-neocortical and the limbic systems. Ketamine dampens the thalamo-neocortical system 
causing analgesia or better anti-nociception (50). It shows these effects with significantly lower 
blood concentrations compared to those required for unconsciousness. In addition, there is a 
marked sedation or even hypnosis occurs. The depression of the thermoregulatory centre makes 
the animal more susceptible to temperature loss. The pulse rate and BP are markedly increased 
whereas the respiratory rate is decreased and altered to an apnoeic pattern (51). By stimulation 
of the limbic system, the skeletal tone is increased (catalepsy) with maintained or even enhanced 
laryngeal, pharyngeal, lid and corneal reflexes. Ketamine further stimulates the cerebral blood 
flow, metabolism and intracranial pressure as well as stimulating the superior circulatory and res-
piratory centres (52).  
Mechanism of action 
In the CNS ketamine acts as a non-competitive antagonist on the NMDA-receptor, a subtype of 
the glutamate receptor. Binding to the receptor leads to the inhibition of sodium, potassium and 
calcium ion fluxes. It also reduces the presynaptic release of the excitatory neurotransmitter glu-
tamate. Ketamine further agonistically interacts with the mu and kappa opioid receptors, but with 
10 times lower affinity compared to the NMDA-channel.  
Pharmacokinetics 
Ketamine has a high bioavailability of 93 % after i.m. injection and, due to its high lipophilicity, 
passes through the blood-brain barrier easily (52). The pharmacokinetic half-life and duration of 
effect varies depending on the speed of metabolisation, age and general condition of the patient 
but are generally short (clinical duration of 30 min for rodents (43)). Ketamine is metabolised in 
the liver by cytochrome P450 via demethylation and hydroxylation and the metabolites are con-
jugated and excreted in the urine (51). 
Field of application 
Currently, ketamine is marketed in Germany as Ursotamin® 100mg/mL for s.c. and i.m. injection 
for GPs and consists, like the other veterinary ketamine preparations, of both the R and S isomers. 
Meanwhile, the S-isomer, with a 3-4 fold higher NMDA-receptor affinity, was introduced to the 
human drug market. Experiences with its use in the GP have not yet been published.   
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Intramuscular injection of ketamine has been described as painful and cause of muscle necrosis 
(53) due to the low pH of 3.5-5.5 in all marketed ketamine preparations in Germany. In the GP, 
ketamine when used alone does not induce a satisfactory anaesthesia and is, because of its other 
effects, also not used for analgesia. In the veterinary practice and in experimental procedures, it 
is often combined with α2-adrenoceptor agonists or benzodiazepines, however, even these com-
binations are associated with a prolonged recovery and catalepsy (26). 
2.5.9  Ketamine and α2-adrenoceptor agonist combination 
Ketamine combined with xylazine (KX) is the most commonly used injection anaesthesia in the GP 
and has been performed in veterinary practice and in the experimental laboratory with varying 
dosages. The difficulties with this combination are reflected in the divergent literature reports 
concerning anaesthesia depth and duration, number of injections required and difficulties with 
post-anaesthetic recovery. Although the partial antagonisation of xylazine is possible with either 
yohimbine or atipamezole, according to the literature it is not often practiced, possibly because 
of the reported ketamine hangover after xylazine removal (1). The following references summarize 
the anaesthesia experiences with KX use in non-terminal studies (Table 6). 
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Table 6: A recent literature overview on KX use with recovery in GPs. 
 
Ketamine (40 mg/kg) paired with medetomidine (0.5 mg/kg) or detomidine (5 mg/kg) was tested 
by Buchanan, et al. (26) which caused a quick onset of anaesthesia that lasted for 118 –196 / 110 
– 167 min but did not produce adequate analgesia for ovariohysterectomy. Combining ketamine 
with dexmedetomidine (active isomer of medetomidine) is also an interesting option. The dosage 
recommendation of ketamine (40 mg/kg) and dexmedetomidine (0.25 mg/kg) i.p. was issued by 
Flecknell (56), however, so far literature lacks experience statements for the use in GPs.  
Pros and Cons 
KX offers the advantages of using 2 inexpensive active ingredients which are easily combined and 
provide the user with a patient that can be easily moved or repositioned. Also, the application of 
KX is, apart from the risk of self-injection, safe for the operator. Disadvantages include the unreli-
able induction phase of anaesthesia without obvious reasons for the different individual re-
sponses and it can cause muscle necrosis after i.m. injection (53). Catalepsy may occur during 
recovery and there is a long post-anaesthetic recovery with the need for close physiological 
monitoring. There are also reports of ambiguous reflex responses during anaesthesia (1). 
Ketamine  
[mg/kg] 
Xylazine  
[mg/kg] 
Purpose/ experience Reference 
35 
60 
87 
5 
8 
13 
i.p., 87/13 combination can be used for restraint 
and mildly painful procedures but not for major 
operative procedures. Dose dependent reduction 
of body temperature and respiratory rate 
Radde, et al. (25), 
1996 
40 
60 
5 
5 
i.m., both dosages failed to provide adequate an-
aesthesia to perform ovariohysterectomy 
Buchanan, et al. 
(26), 1998 
80-100 2-3 i.m., “risky” anaesthesia extension, interdigital re-
flex response often persisting 
Henke (1), 1998 
20 5 i.v. infusion, surgical anaesthesia was attained at 
low doses. During the experiment, the animals 
didn’t experience adverse side effects 
Schwenke et al. 
(28), 2004 
30 5 i.m. provided 30-50 min of anaesthesia for proce-
dure requiring restraint (echocardiography) 
Çetin, et al. (54), 
2005 
30 2.5 s.c./i.m./i.p., suitable for routine procedures up to 
45 min (bleeding from the vena cava)  
Dang, et al. (31), 
2008 
15 
20 
5 
8 
Ketamine i.p., xylazine i.m., abdominal ECG 
radiotelemetry implantation 
Stemkens-Sevens, 
et al. (55), 2009 
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Field of application 
KX may be used for many procedures requiring anaesthesia in the GP (see Table 6). Within veter-
inary medicine, KX is used with great success in many animal species (cat, dog, cattle), it is readily 
available and inexpensive. Therefore KX may comprehensively also be applied to GPs by a user 
with little GP experience, someone who is unaware of the new options in the anaesthesia field or 
for whom the MMF anaesthesia is not profitable. This occurs in common practices with a low small 
mammal share or in the research field with long-term established study designs which asks for a 
special design or reproducibility.  
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2.6  Inhalation anaesthesia 
Another method of inducing anaesthesia is the exposure to the active ingredient with the breath-
ing air. Inhalation anaesthesia provides very quick anaesthesia level adjustability that is not possi-
ble with injectable anaesthetics. The inhalation anaesthetics methoxyflurane (57), halothane (58), 
enflurane (59), isoflurane (Iso) and sevoflurane (11) have been tested in the GP (see following 
paragraph). As explained below, Iso remains as the only realistic option from this selection and is 
therefore dealt with in more detail in the following subchapter.  
The induction of volatile anaesthetics in GPs is performed by exposing the whole animal to the 
narcotic gas (Fig 1). After the loss of the RR the anaesthesia can be maintained by further admin-
istration using a nose cone (Fig 2). Macedo, et al. (8) combined ketamine (15 mg/kg) and butor-
phanol (1mg/kg) for the induction of anaesthesia and maintained a surgical level of anaesthesia 
for fixation of a fracture with Iso (no stated vol. %) thereafter. They describe the premedication 
and maintenance as uneventful. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cooke (58) experimented with halothane in the GP (2.25 vol. % maintenance) and reports a “re-
turn to consciousness” after 10 min. Seifen, et al. (59) determined the MAC (minimal alveolar con-
centration, 50 % of patients do no longer show a reaction to a pain stimulus) of halothane with 
1.01 vol. %. It leads to extreme dose dependent cardiovascular (52 % decrease in mean arterial 
blood pressure; 30 % decrease in HR, (60)) and respiratory depression and increases broncho-
secretion. The 20 % degradation in the liver produces highly toxic metabolites which can cause 
liver cell necrosis (60). Further disadvantages are its lack of analgesic effect, mild hypnosis and 
Fig 2: Nose cone used for the maintenance of 
Iso anaesthesia in GPs. 
Fig 1: Whole body chamber used 
for the induction of Iso in GPs. 
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unsatisfactory relaxation (61). In Germany it is no longer used in the GP, but it was recently chosen 
for anaesthesia in a Japanese study (62). 
The newest inhalation anaesthetic in veterinary medicine is sevoflurane which provides the quick-
est on- and offset of anaesthesia and has been investigated by Heide (11) in the GP. It required 
7.8 vol. % for a loss of the RR which was accomplished after approximately 4.5 min and 7 vol. % to 
maintain the anaesthesia. Premedication with atropine prevented a saliva production in the in-
duction phase. Even with premedication, 16 of 22 GPs developed gasping breathing up to 25 min 
after induction and had to be resuscitated with oxygen and tilting. The respiratory rate decreased 
to 21 breaths per minute. Based on this outcome, Heide (11) advised against the use of sevoflu-
rane in the GP. 
2.6.1 Isoflurane 
Iso is a halogenated methyl ether with 5 fluorine ions and was synthesized for the first time by 
Ross Terell in 1965. It is a clear, volatile liquid and is neither explosive nor inflammable. The rather 
pungent ether-like smell is reported to cause aversive reactions in animals. 
Pharmacological effect 
Iso is strongly hypnotic and muscle relaxing, but not considerably analgesic in clinical doses (61). 
Seifen, et al. (59) determined the MAC of Iso with 1.15 vol. %. In the cardiovascular system, there 
is a decreased peripheral resistance with a resultant fall in systemic BP, reflex tachycardia (43) and 
a reduction of renal blood flow with lower glomerular filtration rate. The respiration is dose de-
pendently depressed and the gas irritates the airways causing salivation and bronchosecretion 
(11,61).  
Mechanism of action 
The detailed mechanism of action of volatile anaesthetics is not yet fully understood. It is, how-
ever, known that the immobilisation is primarily mediated through the depression of spinal neuron 
networks. Grasshoff, et al. (63) found that glycine (39 %) and GABAA (36 %) receptors were mainly 
responsible, but that glutamate receptors and potassium channels also caused some of the relax-
ation. The hypnosis is produced in the CNS by modulation of nicotinic acetylcholine, the potentia-
tion of inhibitory GABAA-receptors und the depression of excitatory glutamate transmission (Cam-
pagna et al., 2003). The changes in blood flow result from multiple factors: the relaxing action of 
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anaesthetics on the vascular smooth muscle, the possible mediatory role of nitric oxide (64), MAP 
(mean arterial blood pressure) decrease through vasodilation, influence of indirect metabolic 
mechanisms following the reduction of cardiac work, pressure-flow self-regulation, and time-de-
pendent vascular adaptation (65). The respiratory function is impaired by the inhibition of the 
respiratory control systems like the feedback of central respiratory centres, chemoreceptors, pul-
monary reflexes and neuronal input thereby altering the oxygen supply and the CO2 elimination 
(66). 
Pharmacokinetics 
Iso is administered with the breathing air by means of a special vaporizer. Its high lipid solubility 
allows a quick entrance into the blood stream and further on into the brain. The low blood solu-
bility ensures the quick on- and offset of effect, clinically observed by a fast adjustability. In the GP 
the induction concentration is 4.5 vol. % which is then lowered depending on the individual ReR 
and reflex responses. Iso is almost fully exhaled and only 0.17 % is degraded over atoxic metabo-
lites. 
Field of application 
Iso is used in common practice and in the laboratory field and is licensed for GP use in Germany. 
In research it is frequently used to anaesthetise GPs for short periods of time or repeatedly on the 
same day. Toxicology studies benefit from the low metabolisation it offers. As small amounts of 
Iso evaporate into the surrounding air during every anaesthesia (e.g. machine or patient piece 
leakage) which affects the anaesthesia operator, special working safety measures need to be met 
such as suctions or the exclusion of especially endangered individuals (expecting mothers). Also, 
the transportability of animals under Iso is more challenging as the gas needs to be constantly 
applied.  
Specialities in the GP use 
Literature reports on Iso anaesthesia in the GP are very limited. The most detailed research has 
been done by Heide  (11). She confirmed older reports on the necessity of premedicating the GPs 
which she performed with 0.04 mg/kg. This decreased the fluid secretion to the mucous but did 
not prevent thick mucous formation after 30 min which became clinically noticeable in breathing 
sounds. Atropine also averagely increased the pulse rate by 42 bpm. 
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Multiple researchers (67–69) subjected GPs to Iso to perform abdominal radiotelemetry transmit-
ter implantation. Apart from performing the implantation, the reference does not state if premed-
ication was used, how long the anaesthesia was maintained or if there were any problems. 
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2.7 Radiotelemetry 
Telemetry originates from the Greek words for “far” and “measure” and means acquiring infor-
mation from a distance. The parameters are collected by sensors on the measuring point and are 
reported to another spatially separated location. With radiotelemetry the acquired information is 
transferred via radio waves. Figure 3 shows the fully implantable radiotelemetry device (PhysioTel 
™ HD-S11, DSI, St. Paul, USA) for small mammals that was used in all GPs in this study.  
The red and the white leads are ECG cables with an inboard wire and outside insulation. The BP 
catheter is made out of plastic, it is fluid filled and the last centimetre is gel filled. The body is 
covered with a silicone that provides 4 eyelets on the side facing down with which it can be sutured 
to the inner abdominal wall. Figure 4 shows the location of the implant in the GP. Due to the 
material properties the BP catheter is not visible. The cable loops in the inguinal and the tracheal 
Fig 3: Fully implantable radiotelemetry device (PhysioTel ™HD-S11, DSI, St. Paul, USA) for small 
animals, 8 g, 5.9 cc volume, minimum animal weight 175 g, 2 months warranted battery life. 
Transmitter body with 2 ECG leads (long white and red) and one blood pressure catheter (trans-
parent led). 
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area are installed during surgery to allow some leeway during movement or in the process of ani-
mal growth. The small loops at the end of the wire enable a better ECG signal compared to straight 
wire ends.  
The implantation approach is basically the same as described in rats (4) but species specific differ-
ences in anatomy (e.g. thinner and more embedded abdominal aorta) and physiology (need for 
absolutely sterile environment) complicate the procedure in the GP.   
Fig 4: Radiotelemetry implant in a GP. The device body is implanted in the abdomen; both ECG 
leads are fixed subcutaneously, one over the trachea and the other over the pectoral muscle. 
The blood pressure catheter is fluid filled, made out of plastic and is therefore not visible. 
2 
1 
3 
Fig 5: Radiotelemetry set up for 8 animals by DSI. 1= device inside the animal, 2= re-
ceiver plate, 3= matrix. 
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Therefore we published our detailed approach in the GP in a separate paper (publication 1) instead 
of adding it to the single anaesthesia description (publication 2). Explanation of the approach is 
therefore skipped at this point. After successful implantation, the GP can be used in the setup (Fig 
5) with places for 8 animals as marketed by Data Sciences International (DSI, St. Paul, USA).In the 
beginning, the individual GPs’ device is powered on with a magnet and from then on, the animals’, 
BP passed along the gel filled tip and fluid filled cable, is recognized by a sensor inside the device 
body (Fig 5.1). For this type of device, the BP signal is audible with a radio. A transmitter modulates 
the BP signal into a frequency modulation (FM) wave which now carries the BP signal via radio 
waves without the need for a direct connection. The radio waves are registered with an antenna 
in the receiver plate which is located below the animals’ cage (2). The receiver plate sends the 
signal to a matrix (3) which demodulates the FM back into a voltage that can then be observed on 
a monitor display. The ECG and activity values are acquired alike. With this device type, the values 
can be observed in real time, providing an excellent tool for monitoring anaesthesia. 
The telemetry technology has existed for more than 50 years, but only the development of afford-
able, smaller and more reliable devices in the last 15 years has allowed it to enter the laboratory 
field (3,4). It has proven itself as a very versatile tool with many benefits. Above all, it eliminates 
artefacts from restraining the animal (4) and allows the investigation of a wide range of areas such 
as physiological, behavioural, welfare and pharmacological research (55). It further reduces the 
animal numbers used in research as one animal can be used repeatedly. Measurements can be 
performed continuously, even outside of usual working hours (70) and over a long period of 
time(71). It is considered the gold standard for acquiring reliable measurements of cardiovascular 
parameters (70) and BT (53).The technique has been validated versus the BP measurement with 
an exteriorized catheter in the GP (72). This is especially relevant for BP measurements as the 
alternative is having to euthanize the animal after direct carotid artery cannulation. Also, the im-
planted animals can still be group housed. These benefits and the large number of acquired meas-
uring points per animal reduce the animal number by 60-70 % in single studies and up to 90% in 
multiple studies (4) thereby adding greatly to the 3R idea. 
A great disadvantage of BP radiotelemetry is the related cost. The installation of a comparable 
setup requires 16 transmitters for small animals, 8 receiver plates, a modulation matrix and an 
analysis software worth a total of approx. 175.000 € on top of unspecific requirements such as a 
measuring room, a small animal surgery room and a computer for monitoring. The implantation 
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of a radiotelemetry device with a BP catheter in GPs requires advanced surgical skill and is accom-
panied with a lower long-term survival rate compared to the rat. Also, the GP BP model requires 
surgery and a long lead time, in our setting at least 5 weeks, before it can be used in a study for 
the first time. The GPs need to be ordered and delivered, they need to acclimatize to the new 
setting, the surgical implantation has to be performed and needs to be successful in a sufficient 
number of animals. Thereafter, a recovery period of at least 1 week is required. A faster entry in a 
research study is not reasonable as the implantation influences contradict the use of the animal 
as a reliable model organism (71). Late onset infections, unrealistic measuring results or fighting 
among the GPs can further reduce the number of usable animals after the critical early stage. 
Furthermore, in the field of safety pharmacology the predictability of results acquired in the GP 
for humans is questioned as the GP physiologically exhibits only about half of the BP seen in hu-
mans. Out of the sum of these reasons, the BP implanted GP is rarely used in the real research 
environment. 
2.7.1 Data analysis 
To be able to show the received anaesthesia signals on a computer display, we used one of several 
data analysis programs, Notocord-hem™ (NOTOCORD Systems, Croissy-sur-Seine, France). In fig-
ure 6, the parameter courses of HR, BT and BP are shown during Iso anaesthesia in a male GP.  
 
Fig 6: Screenshot of an Iso anaesthesia signal read-out with Notocord-hem™ in a male GP, 
monitored by an implanted BP radiotelemetry device. 
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The label, colours, axis scaling and the shown interval can be adjusted individually among many 
other options. With the keys F1-F3 relevant time points can be set. F3 (pink) was used for notes 
like “entering the room”, F1 (yellow) for application of atropine or exposure to Iso and F2 (blue) 
arked the end of Iso exposure. Figure 7 shows the continuous display in which the ECG and the BP 
can be monitored in real time. The data points were then transferred with the add-in “Analysis 
ToolPak” to Microsoft Excel. Each anaesthesia was edited in a separate file and all of them were 
given to the internal statistic department for mathematically correct table and graph design. 
2.7.2 Setup 
The anaesthesias were performed in a closed room, furnished with the radiotelemetry receiving 
equipment. The required anaesthesia devices were integrated into the existing setup, such that 
the whole process of the narcosis (baseline, induction, maintenance, recovery) was performed in 
the same room without re-moving the animals. The single cages were placed directly over 2 com-
bined receiver plates as one device provided a dome-shaped signal range of approx. 30 cm. The 
device signals interfered with each other if they came to close because they all transmit their sig-
nals on the same frequency. Moreover, no metallic materials could be placed between the animal 
and the receiver. For that reason neither the water heating tub used during our implantation nor 
an electrical heating mat could be used during the anaesthesia. The receiver plates were covered 
Fig 7: Continuous display in the Notocord-hem™ software during the signal read-out of a radio-
telemetry signal implanted into a GP. 
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with plastic water heating mats (Fig 8 & 9) attached to smoothly adjustable water baths which 
were protected by surgical drapes. An Iso extraction hood was positioned over one working place 
(Fig 8).  
Each single cage was labelled and equipped with bedding, hay, food pellets, a water bottle and the 
home cage shelter. We observed a faster calm down with transferring the scent of the home cage 
to the new one. The GPs were sitting calmly in their cages except for short initial movements. Since 
the exact anaesthesia procedure is described in publication 1, no further description is given here. 
Fig 8: Suction hood for the performance of Iso anaesthesia in GPs. 
Fig 9: Set up for a radiotelemetry monitored anaesthesia study in male GPs. 
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2.7.3 Blood pressure 
The term refers to the arterial BP. It is the product of the heart minute volume (which is HR x 
beating volume) and the total peripheral resistance. Maintaining it is one of the most important 
physiological functions. It ensures the perfusion of all living organs and tissues, the exchange of 
metabolic products and the oxygen supply. The main organs that suffer from BP deviation are the 
CNS, heart and kidneys (73). There is the invasive and the non-invasive method to measure the 
BP. The non-invasive oscillometry is inexpensive and can be performed quickly on awake animals. 
But this system is very susceptible to movement faults, detects incorrect values at shallow pulse 
waves and is in general less accurate and reliable compared to an invasive approach (4). Since 
2008 the newest generation of non-invasive BP measurement, the high definition oscillometry 
(HDO) (74) has been used in research with good results in many species (75). It enables the per-
formance of a direct high frequency analysis of the incoming pulse signals with a 32 bit processor. 
Also an electronically controlled valve ensures the linear and pulse adaptive air deflation. So far 
this technique has not been tested in GPs. Invasive BP measurements, as performed in this study, 
are achieved by inserting a catheter into a primary artery and thereby directly measuring the pulse 
waves. Our used catheter type is fluid filled with the sensor positioned in the device body. The 
intra-arterially placed tip is sealed with silicone gel to prevent blood from entering and it is coated 
with an antithrombotic layer to prevent a thrombus formation. With the direct measurement, the 
sensor unit can be fully implanted as in our study resulting in living freely moving GPs that can be 
used in studies several times.  
In the GP, the BP is an especially interesting parameter as they exhibit a comparatively low arterial 
BP of around 64 mmHg (MAP (68,76)) which is then further depressed during anaesthesia. For the 
parameter acquisition the pulse wave is measured continuously. The highest and the lowest graph 
point of every pulse wave depict the systolic (Psystolic) and diastolic (Pdiastolic) value (Fig 10), while the 
mean BP is calculated with the use of equation 1. 
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2.7.4 Heart rate 
The HR is defined as the number of ventricle contractions per time, usually per minute (beats per 
minute = bpm). It is a relevant monitoring parameter during anaesthesia and many anaesthetics 
act depressively on the cardiovascular system. Therefore the HR provides a differentiation crite-
rion between stage III1 and the surgical tolerance stadium III2 also enabling the evaluation of the 
analgesic coverage. It can be measured by auscultation with a stethoscope, but this approach does 
not yield scientifically representative results of a GPs fast HR. The pulse oximetry is another non-
invasive method which acquires the pulse frequency via the HR. Devices specially designed for the 
high HRs of small laboratory animals have been introduced to the market for some time. The elec-
trical heart activity is measured in an electrocardiogram (ECG) with subcutaneously implanted 
electrodes. With radio-telemetry there are 2 options of acquiring the HR, either by counting each 
BP wave, or each spike of the QRS complex in the ECG. Because we knew of the low BP and the 
further depression especially with volatile anaesthetics, we questioned the reliability of counting 
every pulse wave. The experts in the telemetry group recommended drawing the HR from the 
parameter which is less susceptible to interferences and therefore the ECG was chosen as the 
basis for HR count. 
Pdias-
Psystolic 
Pulse pressure 
Calculated mean 
Fig 10: MAP signal in a male GP, measured by an intra-abdominally implanted radiotelemetry 
transmitter. 
Equation 1: Arithmetic mean equation for the calculation of mean blood ar-
terial pressure. 
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2.7.5  Core body temperature 
Core body temperature refers to the temperature in the highly metabolic and visceral parts of 
head and torso of a homoeothermic organism. The BT is regulated by the CNS in the region of the 
anterior hypothalamus and is therefore also affected by anaesthetics mostly in a depressive 
manor. Additionally, the disadvantageous body-volume to surface-ratio and the fast metabolism 
of all small mammals requires a tight temperature monitoring. The measured values for BT are 
dependent on the location where the temperature is measured and the technique used for the 
measurement. The common measuring point for temperature measurement in the GP is in the 
rectum which can be performed with either a conventional fever thermometer or a room ther-
mometer with a flexible sensor tip. This method is quick, inexpensive and applicable in awake GPs. 
If performed correctly the rectal temperature values are comparable to the ones acquired using 
an implanted radio-telemetry device (4), however rectal temperature measuring mistakes can eas-
ily occur. The thermometer tip can be placed into the perianal sac or into faeces instead of the 
rectum lumen, or the measurement time may be too short which leads to incorrectly low temper-
atures. Also the stress of restraint is known to increase the body temperature. In radio-telemetry, 
the temperature sensor is embedded inside of the abdominally implanted device body and collects 
measurements multiple times per second. The above mentioned sources of error in the rectal 
measuring approach are thereby prevented. 
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“Successful implantation of an abdominal aortic blood pressure transducer and radio-telem-
etry transmitter in guinea pigs - Anaesthesia, analgesic management and surgical methods, 
and their influence on hemodynamic parameters and body temperature” 
 
Schmitz, S., Henke, J., Tacke, S., & Guth, B. (2016). Journal of Pharmacological and Toxico-
logical Methods, 80, 9-18. (77)  
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“Comparison of Physiological Parameters and Anaesthesia Specific Observations during 
Isoflurane, Ketamine-Xylazine or Medetomidine-Midazolam-Fentanyl Anaesthesia in Male 
Guinea Pigs” 
 
Schmitz, S., S. Tacke, B. Guth, J. Henke. 2016: PLoS ONE 11, no. 9: p. e0161258. (78)  
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“Repeated anaesthesia with isoflurane and medetomidine-midazolam-fentanyl in guinea 
pigs and its influence on physiological parameters” 
 
Schmitz S., Tacke S., Guth B., Henke J., 2017: PLoS ONE 12, no. 3: e0174423. 
https://doi.org/10.1371/journal.pone.0174423 (79) 
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6 General discussion  
6.1 Study aim 
This study’s aim was to test the influence of the 3 most commonly used anaesthetics in GPs on 
their physiological parameters, focusing on the anaesthesia relevant parameters HR, BP, BT and 
ReR. With the aid of implanted blood pressure radiotelemetry devices, the anaesthesia was moni-
tored continuously from 2 hours before anaesthesia until at least 4 h after anaesthesia induction. 
In the first part of the study, the effect of one-time anaesthesia with MMF, Iso or KX was investi-
gated. The second part looked at the effect of repeatedly administered Iso and MMF, for which 
each GP was anaesthetised 2 times per week over 3 consecutive weeks, resulting in a total of 6 
anaesthesias. The examinations of the effects were revealing and significant effects on the physi-
ological parameters could be demonstrated. 
6.2 Discussion for publication 1 
This is the first publication that addresses the critical 24 h after abdominal surgery in the GP. Many 
findings can not only be useful for radiotelemetry implantation but may also be applied for all 
other types of abdominal or major surgeries in GPs.  
The implantation of the blood pressure catheter provides the most robust results, but has the 
disadvantage that the animals must be opened abdominally. Of course, other arterial implant sites 
are also conceivable for measuring peripheral arterial blood pressure (67,68). Implanting the 
blood pressure transduce into the carotid artery, avoids opening the abdominal cavity which is 
associated with a faster hypothermia, a bigger incision, the need to handle the intestine and gen-
erally a longer recovery. In our case, however, this approach was not feasible. The device body 
would need to be positioned subcutaneously on the animals’ neck because of its large size. In this 
case, however, the length of the blood pressure catheter of 8 cm is not sufficient to guarantee 
sufficient movement margin during movement and for the size growth of the animal. Maintaining 
the sterility throughout this implantation approach would be challenging. Furthermore, a skin thin-
ning over the device body, implanted on the neck, has been described (67). Therefore, and be-
cause the internal working group was practiced in the abdominal implantation approach, we de-
cided to take the abdominal approach. 
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Although the general surgical approach is similar to rats, performing the surgery in GPs is much 
more complicated. Of course, any implantation should be strictly sterile, but in reality rats forgive 
small deviations from this claim. GPs don’t. They require strict sterile conditions for the successful 
BP implantation. Furthermore, a GP’s abdomen remains quite barrel shaped, resulting in difficult 
visibility and preparation of the abdominal aorta. Thus, reliable positioning of the aortic clamps is 
made more difficult in GPs. For the correct positioning of the clamps, the tissue around the v. cava 
and a. abdominalis must be dissected, but this has to be done in a tissue sparing way, since a too 
brisk approach can lead to muscle and nerve irritation. A GPs intestine is more voluminous, con-
sumes valuable working space for the abdominal aortic catheterisation and requires gentle han-
dling. From experience, PD Dr. Henke knew that if the intestinal convolutions were little manipu-
lated during implantation, the GPs returned to normal feeding behaviour after the procedure. To 
create more working space, the intestines may be lifted from the abdominal cavity. However this 
accelerates the hypothermia and requires consistent tissue moistening. GPs have thinner and 
more fragile blood vessels than rats and therefore the v. cava and abdominal aorta can rupture 
easily. This occurred in 50% of Provan, et al. (67) GPs, leading to their death. Dissecting and clamp-
ing the abdominal aorta was challenging and caused bleeding in 3 cases, but they were nonfatal. 
All of these differences mean that GP implantation is longer, much more complex and riskier com-
pared to the rat.  
 
Other groups have also published their results of abdominal BP radiotelemetry device implanta-
tion in the GP. However, they described long-term survival rates between 0 % (67) and 64 % / 74 
% (68). The latter group used Iso anaesthesia for their implantations. However, they did not pro-
vide information on a possible premedication or for which reason some animals died. In our sec-
ond publication, we were able to confirm the already existing findings (11) that Iso leads to a 
strong respiratory depression in GPs and an increased risk of apnoea. In the investigation by Heide 
(11), the GPs also developed rattling breathing sounds after 30 min of Iso maintenance, wherefore 
she recommended the use of Iso only for anaesthesias up to 40 min. Additionally, we were able 
to show that the blood pressure during Iso exposure remains constantly low. With this unfavour-
able combination of physiological influences, a sufficient supply of oxygen to the tissues, especially 
the brain, may not be guaranteed during long anaesthesia. Our mean anaesthesia duration was 
on average 131 min.  
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For such a long anaesthesia (on the average 131 min), in which the GPs had to be maintained 
under anaesthesia without narcotic emergencies, Iso was too risky and MMF injection anaesthesia 
was chosen. 
6.2.1 Analgesia 
Precise descriptions of the analgesic protocol and the use of a multimodal approach (80) (combin-
ing analgesics with complementary mechanisms of action) are rare in the work with laboratory 
GPs. It has long been known that pain influences almost all organ systems (81) and may thereby 
impact study results. If an analgesic regimen is necessary, then it must be started early on and 
must be maintained for an adequate duration as well as on a consistently level. The choice of Iso 
as the main implantation anaesthetic of the other group (68) has already been discussed above, 
with regard to the influence on the physiological parameters. Viewed from analgesia points, Iso 
has no relevant analgesic component. In addition to Iso, this group used 50 mg/kg of tramadol s.c. 
and a single dose of 3 mg/kg carprofen during the surgery. The postoperative pain was treated 
with 25 mg/kg s.c. tramadol every 24 h for 2 days. Tramadol may be used for adjunctive treatment 
but is not analgesic enough as a sole agent (82) and also has a very short half-life time (no phar-
macological data for GPs; 1.1 h in the mouse, 3.0 - 3.9 h in the rat (83)). The applied dose of 
carprofen was below the recommended dose of 4-5 mg/kg BW and day (49), NSAIDs only treat 
pain originating from inflammation and correct dosing of carprofen is challenging in the GP be-
cause of the high drug quantities in tablets (20 mg) and solutions (50 mg/mL).  
With the analgesic possibilities available for GPs, we have aimed to implement an extensive, mul-
timodal pain regime. During the implantation, the GPs were covered with fentanyl, metamizole 
and meloxicam. The abdominal incision line was infiltrated with lidocaine to stop muscle contrac-
tions when the skin was incised. This also blocks pain stimuli from being forwarded to the brain 
and can thereby prevent long term pain sensitization (84). Meloxicam is superior to carprofen in 
that 0.5 and 1.5 mg/mL oral suspensions are available (Vetidata 11.2016). Metamizole has a simi-
larly short application interval (estimated in GPs every 4-6 h) compared to tramadol, but has com-
parable analgesic potency to opioids, rarely provokes relevant side effects and can be applied 
orally with a fast onset (85). With this analgesia regime, our GPs started increasing their BW after 
the second day after the operation instead of after one week (68). 
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6.2.2 Radiotelemetry technique 
This technique is considered the gold standard for the collection of physiological signals in unre-
strained, conscious animals (43). By using the radiotelemetry technique, we have been able to 
achieve previously unknown data results, including baseline and recovery parameters in calm, un-
restrained GPs. The same animal could be closely monitored during repeated anaesthesia and the 
observation of cumulated anaesthesia effects was possible for the first time. The high sample rate 
of the physiological signals (500 Hz for BP) eliminated rounding errors or large gaps from graphs 
which was especially useful in the anaesthesia induction and wake-up phases. The usability of the 
implant depends decisively on its battery performance. It was sufficiently long that we did not 
have to exclude a GP because of signal loss from the data evaluation from the beginning of the 
implantation until after the end of the anaesthesia repetitions. Similarly, Hess, et al. 70 were able 
to perform measurements until the end of the battery life (< 8 months). This long possibility for 
data collection relativizes the high effort associated with the successful implantation of BP trans-
ducer in GPs. Of course, the radiotelemetry technique also has disadvantages, such as the very 
high installation price and the long transitional period until an implanted GP can be used for the 
first time in a study. In our study, with the habituation, surgery and recovery, it took 35 days until 
the first anaesthesia was performed.  
6.2.3 Vitamin C 
As mentioned in chapter 2.3, GPs are dependent on dietary intake to cover their vitamin C supply. 
Their food intake, and with that vitamin C coverage, may, however, be reduced due to illness, 
social stress or after surgery. Deficiency symptoms include loss of energy, weakness, wound heal-
ing disorders, strong or inner bleeding, rough hair coat and reduced appetite. Normally, the food 
for laboratory GPs contains an adequate vitamin C amount. Recommendations suggest daily dos-
ages between 10-30 mg/kg (86). After surgery, GPs are expected to suspend their food and water 
consumption for varying durations of time. We were unsure about the need for vitamin C supple-
mentation, since the animals had no clinical signs of under-supply and there were few published 
data about the use of vitamin C in combination with surgery. However, because we wanted to 
avoid losing GPs due to vitamin C under-supply, we began daily oral supplementation with 20 
mg/kg vitamin C dissolved in water, starting 7 days before the implantation until 14 days thereafter 
(68). The results with the supplementation of vitamin C were compared to our own experiences 
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during our training implantations which were performed without vitamin C supplementation. With 
vitamin C, we found that the skin incisions healed faster and with lesser complications and that 
the GPs recovered faster overall. These observations are so far just clinical observations and need 
to be confirmed by an appropriate study design. However, up to this point, the oral supplementa-
tion was without side effects, vitamin C is easily accessible and in-expensive and the solution is 
easy to administer orally. Therefore, according to our experience, we can recommend a vitamin C 
substitute for those procedures which might reduce the food intake in GPs.  
6.2.4 Stress 
The behaviour of mice and rats cannot be applied to GPs (7). When stressed, GPs will not show 
“usual” stress symptoms, like running around or aggressive behaviour. Instead, they will respond 
with inconspicuous symptoms like “freezing” in a cage corner. Although clinically invisible, their 
physiological parameters will be altered. Examining the changes of the physiological parameters 
(BP, ECG, BT) with radiotelemetry is, therefore, superior to manual measuring because this is ac-
companied with handling stress. To illustrate this point, the effect of short, non-painful transport 
on the HR and BT in a healthy awake GP are pictured in figure 11. Before 0 min, the GP was re-
moved from its home cage, weighed, placed in a single cage with the familiar home cage shelter, 
put on a trolley and transported over a distance of 15 m into the measuring room. This whole 
process lasted approx. 5 min. When the measurements began at 0 min, the GP was sitting in its 
cage without moving and it also remained mostly still throughout the 2 h. The HR and BT influence 
were therefore indistinguishable by means of checking the GPs behaviour.  
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This graph shows that after transport, GPs need an adaptation time to return to physiological rest-
ing values before values for use in a study can be measured. Since we could already show such 
physiological effects for a short, simple transport, and they were clinically invisible, we have tried 
in total to save the GPs as much stress as possible. Our focus was especially on a quiet environment 
and safe handling, performed by familiar staff. The quiet and secure handling was rewarded with 
lesser stress symptoms like freezing, hectic movements or loud squealing. Although this behaviour 
should be used in all animals, it is especially necessary in GPs, since they could otherwise suffer 
unseen under avoidable stress. 
Fig 11: HR and BT directly after transport to the telemetry room (0 min) and the end of habitu-
ation time (2 h later). 
38.9°C 
39.7°C 
260 bpm 
224 bpm 
36 bpm 
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6.3 Discussion for publications 2 and 3 
6.3.1 Baseline 
In chapter 6.2.4, it has already been shown that stress (here transport stress) changes the physi-
ology of GPs without clinically conspicuous behaviour being visible. Baseline measurements are 
therefore necessary to capture the possible day-to-day fluctuations. Ideally, these data sets should 
be acquired just before the start of the study measurements which was performed in a compara-
ble study in rats (53). Although multiple animals were measured in the same room, induction of 
anaesthesia in one rat did not affect the other rats’ physiological parameters. This measuring ap-
proach was not possible with GPs. Fig 12 (black frame) shows that the physiological parameters in 
this GP changed slightly when the measuring room was entered and anaesthesia was induced in 
another animal.   
In addition, at the end of a 4 h acclimatisation period, the HR and the BT were slightly lower com-
pared to the values at 2 h, as seen in the GP in Fig 12. According to this, baseline measurements 
just before the start of anaesthesia would not have been comparable between the GPs. Therefore, 
the baselines for all animals were determined prior to the first anaesthesia of the day. 
Fig 12: Impact (black frame) of the start of an anaesthesia in another animal in the same room 
(1st pink marker = entered the room) on the baseline values of this GP.  
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The following Table 7 shows descriptive baseline values for BP, HR and BT prior to the anaesthesia 
with MMF, Iso or KX, averaged over 2 groups of GPs with 5 months between the groups. These 
values can be considered to be reference values for these parameters in the unstressed, conscious 
GP. 
Parameter Treatment N Baseline 
SAP [mmHg] 
  
  
MMF 11 66.9 ± 2.7 
Iso 13 66.3 ± 5.0 
KX 7 68.3 ± 3.4 
  
DAP [mmHg] 
  
  
MMF 11 48.1 ± 2.7 
Iso 13 48.4 ± 3.8 
KX 7 48.5 ± 4.7 
  
MAP [mmHg] 
  
  
MMF 11 57.6 ± 3.3 
Iso 13 56.9 ± 3.7 
KX 7 58.9 ± 3.2 
  
HR [bpm] 
  
  
MMF 11 245.8 ± 18.2 
Iso 13 247.0 ± 16.0 
KX 7 237.9 ± 11.1 
  
BT [°C] 
  
  
MMF 11 38.9 ± 0.2 
Iso 13 38.9 ± 0.4 
KX 7 39.0 ± 0.2 
 
The BP is particularly interesting in the GP, because it is much lower compared to other lab animals 
and there are only a few measuring methods (mostly invasive ones) which provide robust results. 
Comparing our baseline BP values to those in the literature showed that our values were lower 
than those of DePasquale, et al. (72) (MAP 61-65 mmHg) and Hess, et al. (68) (MAP 63-68 mmHg) 
although their values were also measured by means of BP radiotelemetry. However, both publi-
cations did not describe after which time the baseline measurements were collected, and what 
kind of handling was carried out beforehand with the GPs. The higher baseline results in the other 
Table 7: Baseline values averaged 
over 15 min at the end of 2 h habit-
uation in male GPs prior to anaes-
thesia with medetomidine-midazo-
lam-fentanyl (MMF), isoflurane (Iso) 
and ketamine-xylazine (KX). 
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two publications could, therefore, be due to the lack of an adequate habituation. These differ-
ences in the baselines may not appear to be large, but count when put in relation to the physio-
logical BP level of GPs. 
6.3.2 Medetomidine-midazolam-fentanyl 
Publication 2 (78) investigated the impact of MMF anaesthesia on physiological parameters in the 
GP for the first time by means of radiotelemetry. The advantages of this measuring technique, 
already described in detail in chapter 2, make it the gold standard with presumably undistorted 
values. Prior to this study, there was no published information on BP, BG or the BT throughout all 
phases of MMF anaesthesia. The results of this study suggest that among the available anaesthesia 
options in the GP, MMF provides the most advantages in the GP. In chapter 2.1 the criteria of good 
adjustability, reliable effect, large safety margin, quick induction and recovery, stress-free applica-
tion for both animal and anaesthetist and low impact on physiological parameters (HR, BP, respir-
atory rate and metabolism) were introduced. Looking at these criteria, MMF provided a fast and 
smooth induction and recovery and the anaesthesia could be terminated at any time or main-
tained by additional injections, as performed for the extension of anaesthesia for radiotelemetry 
transmitter implantation (77) (Fig 13). In an emergency the wake-up can be sped up by adminis-
tering the antagonist i.m. or even i.v.. Injection of the MMF combination reliably led to anaesthe-
sia. The fact that 2 GPs in the publication 2 did not show a surgical tolerance, was presumably 
attributable to the lower level of experience of the anaesthetist, since in the experiments for the 
3rd publication all animals showed a surgical tolerance with MMF.  
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In addition, the use of MMF is safe for the animal with a relatively large volume safety margin and 
there is no need for additional work safety measures, in comparison to working with Iso. It does 
not require expensive equipment and transporting the anaesthetised GP is comparatively easy, 
even though heat and oxygen supply must still be guaranteed. The induction of anaesthesia is 
comparably stress-reduced as MMF anaesthesia does not require premedication and the GPs 
gradually drift into unconsciousness. Furthermore, MMF anaesthesia caused the least adverse 
variations in the anaesthesia safety relevant parameters ReR, HR and BP. On the contrary, among 
the three tested agents, MMF was the anaesthetic that kept the BP closest to the physiological 
levels during anaesthesia. This also ensured a significantly better tissue oxygen supply compared 
to the low BP during Iso anaesthesia. Due to the strong reflex responses caused by MMF, the 
anaesthesia depth can be determined more clearly than with the slowed reflex responses with Iso. 
The provided analgesia which may be maintained for the recovery after painful procedures by 
partial antagonisation, is a unique advantage over KX and Iso.  
Core body temperature [°C] 
Heart rate [bpm] 
Mean arterial blood pressure [mmHg] 
Fig 13: MAP, HR and BT courses are similar 
for the recovery after MMF anaesthesia for 
radiotelemetry implantation (anaesthesia 
duration 131 min, blue) and after sole MMF 
anaesthesia (duration 40 min, red). 
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Of course, the MMF anaesthesia also has its weaknesses. The one with the greatest impact for the 
GP is the occurring hypothermia. In MMF, however, this is only caused by the elimination of the 
central thermoregulatory capacity and not by the loss of temperature by peripheral vasodilatation, 
as with Iso. Although MMF induced the largest increase in BG, the values during anaesthesia were 
not considered to be dangerous for the animal. The rapid return to food intake and self-regulation 
in the other parameters suggests that the BG will return to normal after the end of anaesthesia. 
However, this needs to be confirmed in further studies.  
Study designs in the laboratory environment sometimes require repeated anaesthesia in the GP 
but they are mostly just for immobilisation purposes. Therefore, the anaesthetic selected for re-
peated procedures should only have a small impact on physiological parameters. MMF met this 
ambition, as it only induced negligible changes in the anaesthesias after the 2nd repetition which 
were due to faster metabolic reactions (79). It was particularly striking that the GP typical strong 
BP fall after the antagonisation in the recovery phase could not be shortened by the repetitions. 
Only the duration after the maximal MAP depression until the return of the RR was reduced by 
the anaesthesia repetitions. Furthermore, the large variance of the individual BP levels during the 
anaesthesia maintenance was conspicuous. Such individual differences have not been presented 
previously in the GP and occurred despite the high standardisation level. These individual re-
sponses to the same anaesthesia illustrate the importance of individual monitoring of each anaes-
thesia. The studies further showed that in the case of repeated anaesthesia the BG levels increased 
more, if there were only 2 days instead of 3 days between the anaesthesia applications. The dif-
ferences in BT between the single and the repeated MMF anaesthesia are associated with the 
different sizes of the GPs used during the study. The GPs that were anaesthetised for the single 
MMF anaesthesias, were smaller and therefore lost BT more quickly (study interim of 28 d, 123 g 
BW difference, Fig 14 green graph). 
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This deficit required a longer thermoregulatory shivering in the recovery phase which was associ-
ated with an increased HR. The regular recurrence of the MMF combination also with older ani-
mals, proved the constant effect of MMF anaesthesia in GPs. The stress factor of anaesthesia plays 
an important role in GP anaesthesia at such short intervals. With this focus, MMF is preferable to 
Iso anaesthesia, since without pre-medication it only requires a one-time handling and an enables 
an undisturbed induction. Among the 3 investigated anaesthesias, MMF is the combination that 
can be recommended for all procedures. Restrictions arise only if several anaesthesias are neces-
sary on the same day, since the antagonisation then interacts with the new MMF application.  
Fig 14: Comparison of the anaesthesia phase times and the MAP, HR and BT courses during sin-
gle (S, green) and 6 times repeated (R, red) MMF anaesthesia in GP, grey lines: -10 min = 
premedication with atropine, 0 min = Iso exposure, 40 min = exposure stop. 
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6.3.3 Isoflurane 
The effect of Iso anaesthesia on BP was never investigated previously using radiotelemetry in the 
GP. This technique is particularly useful for the examination of the strong BP depressing effects in 
the GP because of their already low physiological BP. 
If one again compares the properties of Iso anaesthesia with the criteria for a good anaesthesia 
(chapter 2.1), Iso anaesthesia offers the quickest and easiest adjustability among the three anaes-
thetics. Because Iso is delivered by way of the ventilation, the GP will be anaesthetised as long as 
it’s breathing which cannot be guaranteed for the injectable anaesthetics. The safety margin of 
the amount of anaesthetics, however, is very small for GPs, namely in the tenths of a % range and 
had to be adjusted many times during anaesthesias. Since Iso is also effective for humans, the use 
requires the compliance of working safety measures (use of a suction). The anaesthesia induction 
time was short and although the wake-up phase duration was longer than after MMF anaesthesia, 
the time until the GPs regained their RR was still tolerable. After Iso exposure stopped, the GPs 
were quickly able to adjust their physiological parameters back to normal ranges. However, the 
longer anaesthesia was maintained, and the older the animals become, the longer the recovery 
phase lasted with more frequent respiratory sounds. The induction of Iso anaesthesia is more 
stressful, compared to KX and MMF, as it requires a double handling due to the atropine premed-
ication. This was mirrored by a HR increase during induction and the first part the maintenance 
(publication 2, p. 53, fig. 8) (11). Insertion into the whole body chamber and the irritation of the 
mucous membranes by the gas in the wake state also caused strong defense and excitatory reac-
tions in the animals. As a result, they did not fall asleep as quietly as with MMF. Also the injection 
in the neck must function at the first, maximum at the second try, since otherwise the animals will 
not sit calmly on the arm anymore. This puts a performance pressure on the anaesthetist. 
Compared to MMF, Iso induces massive changes in many physiological parameters. The HR and 
BG remain almost unchanged to the physiological level during Iso anaesthesia. However, Iso was 
the anaesthetic that induced the most undesirable changes during the anaesthesia maintenance 
concerning the BP, ReR and BT. BP and ReR dropped severely during Iso maintenance (respiratory 
emergency 11) and this can only be handled for short anaesthesia because the animals return very 
quickly to their baseline levels after the stop of the Iso exposure.  
As intubating GPs is very difficult and therefore not advisable, they need to breathe on their own 
during anaesthesia which is not ensured during Iso exposure. The breathing is restricted by a very 
low ReR and also by impaired ventilation due to mucous production which blocked the airways. 
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Atropine can reduce the mucous volume transiently, but even s.c. injection which provides the 
longest possible action duration, only reduced the mucous production for approx. 40 min of Iso 
anaesthesia (11). Even if a complete prevention of the mucous production could be reached (re-
newed or nasal (87) atropine administration, glycopyrrolate), the reduced ReR cannot be compen-
sated by medication. Despite the exceptionally high attention to anaesthesia, resuscitation could 
not be prevented in some GPs during Iso exposure. Had this occurred during an invasive surgery, 
the resuscitation would have caused the GP to reawaken from Iso anaesthesia and the break in 
surgical sterility would have endangered the animal’s survival chances. 
The combination of a very low BP, a highly reduced ReR and only slightly increased HR during Iso 
maintenance creates a serious risk for inadequate peripheral tissue oxygenation. In this context, 
the hypotension during Iso anaesthesia was suggested to be the cause for hearing loss in GPs (88). 
It is questionable, if a GP’s brain is sufficiently supplied with oxygen during long Iso anaesthesia. A 
possible neuronal damage is challenging to assess in the GP and, if present, remains mostly unde-
tected. Therefore, Iso anaesthesia should be performed no longer than 40 min not only because 
of the increasing risk of respiratory impairment, but also because of the risk of tissue ischemia. 
Among the three anaesthetics, Iso led to the fastest and most pronounced BT drop. However, this 
can be counterbalanced by a good heat management and the short wake-up also enabled a quick 
return to an autonomous BT regulation. The rapid BT loss can therefore be dealt with, whereas 
the BP and respiratory depression are difficult to counteract. Additionally, the use of Iso comes 
with further using challenges. Transporting the animal while maintaining Iso anaesthesia requires 
continuous exposure to the gas and is, therefore, harder to achieve in comparison to injection 
anaesthesia. As Iso does not provide analgesia, procedures under Iso anaesthesia demand addi-
tional analgesia. Overall, the required level of attention and monitoring during Iso anaesthesia was 
considerably higher compared to MMF anaesthesia and difficult to maintain by one person during 
work intensive procedures. The impact of Iso is critical, but its use is tolerable for short and, above 
all, painless procedures like substance applications. Overall, Iso’s anaesthesia profile has more 
negative effects on the physiological parameters in GPs in comparison to the MMF anaesthesia 
which is why Iso is not the first choice for GPs. 
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The repetition of Iso anaesthesia did not alter the profile of effects on the parameters measured 
(79) (Fig 15). The observed differences between the single and the repeated Iso anaesthesias are 
just like with MMF, associated with the different BW of the GPs.  
A faster and more severe BT loss during single Iso anaesthesia was observed which was associated 
with a more intensive shivering that affected the HR in the recovery phase. The basal HR prior to 
the repeated anaesthesias was lower compared to the single anaesthesias which was also seen 
with MMF anaesthesia. Either the GPs in the repeated study had adapted to the study environ-
ment over time, or those animals in the single anaesthesia study had a higher sympathetic tone. 
The latter is further supported by the need of younger animals for a higher HR to compensate for 
their lesser cardiac output. 
Despite the desirably small effects of the anaesthesia repetitions on the physiology, the adverse 
effects of Iso on the BP, ReR and BT still remained. In contrast to the younger GPs during the single 
Fig 15: Comparison of the anaesthesia phase times and the MAP, HR and BT courses during single 
(S, orange) and 6 times repeated (R, blue) Iso anaesthesia in GP, grey lines: -10 min = 
premedication with atropine, 0 min = Iso exposure, 40 min = exposure stop. 
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anaesthesia, the older and heavier animals during the repeated Iso anaesthesias became increas-
ingly more susceptible to respiratory depression while they were exposed to Iso. Therefore, the 
older GPs could only be dosed for a minimally positive FWR and IG and the lower Iso concentration 
during anaesthesia maintenance led to correspondingly shorter recovery times. In the course of 
the Iso anaesthesia repetitions, the GPs showed increasingly more and stronger defensive reac-
tions to the premedication. This increased the risk for incorrect atropine premedication and there-
fore for respiratory incidents. Performing repeated anaesthesia with Iso is possible but should be 
carefully weighed, even for short, non-painful procedures. However, for a study design requiring 
multiple anaesthesias per day, Iso is the only anaesthesia option because the antagonisation of 
the MMF anaesthesia would prevent a renewed MMF application in such a time frame.  
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6.3.4 Ketamine-xylazine 
KX was used in GPs many times (see 2.5.9), but the measurements of the BP, HR and BT have never 
been performed with radiotelemetry before. KX requires with only 3 substances (KX and atipame-
zole) fewer components than MMF (total of 6 narcotics) does and just like with MMF the injection 
allows the anaesthetized animal to be moved easily. The time until the RR was lost was short and 
the ReR, BT and HR were only moderately affected during KX maintenance. 
However, the large number of KX publications and the different component dosages reflect KX’s 
still existing disadvantages. We had to abandon our preferred i.m. injection site in the hind limb 
because it led to muscle necrosis in rats (53) due to ketamine’s low pH. Instead, we performed an 
altered i.p. injection (89) with the GPs’ hind feet in contact with a solid surface (Fig 16) which led 
to fewer defence movements. Despite the more reliable in-
duction of anaesthesia, only 7 out of 13 GPs reached a surgical 
tolerance which could have been because of failed injections 
into the intestine or because of different responses to the an-
aesthetic. However, the biggest drawback of KX anaesthesia 
was seen in the wake-up and recovery period. Despite partial 
antagonisation, the GPs were unable to right themselves for 
close to an hour. They developed a persistent catalepsy and 
lay on their backs in a crouched position without being able to 
turn around (publication 2, p. 55, Fig. 7). When the GPs finally 
returned to their RR, this state was also not stable. The GP ra-
ther fell back into a sedated state, so that a renewed turn on 
the back was not promptly answered with a position correc-
tion. When the FWR and IG were tested between the antago-
nisation and the return to the RR, the GPs responded with loud squealing and excessive reflex 
responses. The partial antagonisation with atipamezole produced a BP drop from which the GPs 
recovered only slowly. The omission of atipamezole would, however, be even more disadvanta-
geous, since a wake-up duration of 182 min has been reported after unantagonised KX anaesthesia 
in rats (53). The BT did not fall as low as during MMF or Iso anaesthesia, but it decreased further 
after partial antagonisation and the hypothermia and a lack of food and water intake persisted 
long after the GPs had regained their RR. Hypothermia and hypoglycaemia have been named as 
the main causes for anaesthesia-related death in small mammals (9). With 2 of our GPs the BT 
Fig 16: Intraperitoneal application 
in a GP. 
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dropped below 35°C and the GPs may have died without our external warming. Overall, our GPs 
probably survived the KX anaesthesia because none of them had a primary illness which would 
have raised the anaesthesia- and sedation-related risk considerably (9). Because of the uncertain 
anaesthesia induction and the long wake-up and recovery with disadvantageous effects on BP, BT 
and muscle tension development, KX anaesthesia should not be performed in the GP. MMF pro-
vides a better alternative for injection anaesthesia in the GP. However, if the combination is cho-
sen for GP anaesthesia, close supervision is compulsory until the animal returns to normal behav-
iour and BT. 
The disadvantageous effects of KX anaesthesia were even more severe, if the anaesthesia was 
repeated, something which was investigated in the rat (90). Of 6 rats, one died in the 6th repetition, 
in 25 % of the repetitions the animals remained surgically intolerant, 4 rats developed tissue ne-
crosis after repeated KX i.m. injection and all animals lost BW with increasing number of KX repe-
titions. The results of the single KX anaesthesia made a similar course during KX repetitions in the 
GP very likely. Overall, there is no reason to consider performing repeated KX anaesthesia in GPs 
and it was therefore excluded from the repeated anaesthesia study.  
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7 Conclusion 
GPs have been shown to be challenging anaesthesia patients. Until now, there have been no stud-
ies that have examined the effects of different anaesthesias on physiological function in the GP, 
as a means of understanding why they may be so difficult to anesthetise successfully. To address 
this, we have used an experimental approach (radiotelemetry) to provide high quality, continuous 
measurement of the parameters of interest. The implantation of the radiotelemetry transmitter 
into the GPs could be performed reliably with MMF anaesthesia and its use can serve as an exam-
ple for abdominal surgeries with the GP in general. Although a large skin portion was warmed 
during the procedure, the GPs developed substantial hypothermia during the operation. Despite 
the invasive procedure, the animals were able to return their BP and BT to physiological values 8 
h after the implantation and their return to BW gain was faster than in any similar study. 
In the individual anaesthesia tests MMF anaesthesia caused the smallest deviations from the base-
line, physiological values. Apart from the characteristic BP decrease after MMF antagonisation, 
the BP was stabile during anaesthesia and the short wake-up time enabled the quick compensa-
tion of hypothermia. Furthermore, MMF anaesthesia induced only a slight decrease in ReR and 
the BG increased during MMF anaesthesia. Iso led to short anaesthesia induction and wake-up 
times, but caused a strong decrease in BP and a severe ReR depression despite the premedication 
with atropine. During anaesthesia maintenance the Iso concentration had to be constantly ad-
justed and the balance between surgical tolerance and intolerable respiratory depression was dif-
ficult to maintain. The influence on the HR and the BG were negligible, but the BT dropped to the 
lowest values among the 3 anaesthetics. KX had a mild influence on the hemodynamic parameters 
during the anaesthesia maintenance, but the necessary partial antagonisation induced a BP drop 
which was only slowly compensated for. Substantial disadvantages of KX were seen in the very 
long weak-up phase, the unreliable achieving of a surgical tolerance and the long-lasting hypo-
thermia. 
The repetition of MMF and Iso anaesthesia revealed that their profiles were mainly unaltered, but 
the GPs developed increasingly more defense reactions against anaesthesia induction which made 
the induction of anaesthesia progressively more uncertain. During MMF anaesthesia mainte-
nance, the GPs showed conspicuous BP variances. Because of the disadvantageous wake-up and 
recovery phase in the individual anaesthesia protocol, the effects of repeated KX anaesthesia were 
not tested at all. Thus, Iso and MMF can be recommended for repeated use.  
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Based on these results, Iso should only be used for short and non-painful anaesthesias and KX 
should not be used at all in GPs. MMF displayed the best overall profile and is recommended for 
all studies in GPs needing anaesthesia, except studies related to BG effects or those requiring mul-
tiple anaesthesias on the same day.
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8 Lessons learned 
Besides the investigated study results, I also gained more general learning successes, like how to 
approach an unknown, scientific topic and how to establish a new technique. As each person who 
is new to handling GPs, anaesthesia or to radiotelemetry will find themselves in a similar starting 
situation, I’d like to provide them with my main learning successes. 
 
„Practice makes perfect“  
Practising the whole process before the start of the study enabled me to prevent major flaws and 
changes while the study was already ongoing. I went through all processes before the start of my 
real project and applied the “Plan-Do-Check-Act” (The Deming Cycle). 
 
“The only mistake you can make, is not asking for help” – Sandeep Jauhar 
Being inexperienced in basically every field at the beginning of my project, it was essential to col-
lect expertise. Learning from the experiences of others has spared me many mistakes and I always 
encountered a great willingness to share the already acquired knowledge. 
 
Like any study, this also aimed at a maximum of standardization and reproducibility. Nevertheless, 
there was no possibility to completely rule out the learning effect. It may be reduced by careful 
preparation and practise but to some amount, learning, experience and therefore better results 
always occur over time. Therefore I am aware that the acquired results may be different (especially 
success rates for long-term survival after implantation or anaesthesia induction), when the exper-
iments are performed by someone with another level of experience. Learning was probably the 
reason why only 11 of 13 GPs reached the surgical tolerance during the single MMF anaesthesia, 
whereas all GPs became surgically tolerant during the repeated application. However, I believe 
that this is a “general” reproducibility mistake which everyone encounters. Limiting it as much as 
possible by practicing and learning is essential but thereafter it just needs to be accepted. 
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9 Outlook 
Further questions have emerged from the answers received and they are listed below for future 
research projects in the GP. 
 
1. Atropine/Iso 
a. How long does one atropine injection in a GP last (with different dosing)?  
b. Could atropine also be administered over the nose?  
c. Can the breathing sounds be eliminated in the later phase of Iso exposure by applying an 
additional atropine dose? 
d. Would scopolamine or glycopyrrolate premedication provide a more beneficial effect on 
the breathing in the GP during Iso anaesthesia? 
2. BG 
a. What are the BG values before and after MMF and KX anaesthesia in the GPs? (Maybe test 
them with the methods of Birck, et al. 7 or implantable BG systems by DSI) 
3. KX modification 
a. Investigation of anaesthesia with S ketamine + xylazine. 
b. Investigation of anaesthesia with ketamine and dexmedetomidine. 
4. MMF 
a. How long does one MMF injection induce anaesthesia? 
b. How long can the surgical tolerance/ the loss of righting be maintained? 
c. Comparison of question 4a & b in different small mammal species. 
5. Does the high definition oscillometry produce reliable data in the GP? 
6. ReR measured with plethysmography in the GP during different states of the animal (resting, 
person entering the room, animal moving, …). 
7. Which reflex is lost when? 
a. Foot withdrawal reflex hind leg/ front leg;  
b. interdigital reflex hind leg/ front leg;  
c. inguinal reflex left/ right. 
d. Does the response change when the test is repeated? After which number of repetitions? 
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10 Enclosures 
10.1 Physiological Parameters in GPs 
Parameter Measuring unit Awake value 
Mean arterial blood pressure mmHg 53.2-62.1 
Systolic arterial blood pressure mmHg 61.3-72.0 
Diastolic arterial blood pressure mmHg 43.8-53.2 
Heart rate beats per min 219-263 
Body temperature °C 38.5-39.4 
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10.2 Dosage sheet for MMF anaesthesia in GPs 
 
  
6.3 Discussion for publications 2 and 3 
119 
  
10.3 Dosage sheet for MMF antagonisation with AFN in GPs 
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10.4 Typical isoflurane anaesthesia with atropine premedication  
Anaesthesia 
interval 
Induction 
Non- surgical 
tolerance 
Surgical toler-
ance 
Wake-up Recovery 
Definition 
Isoflurane 
exposure  
to RR - 
RR – 
to FWR/IR < + 
FWR/IR < + 
to isoflurane 
stop 
FWR/IR > + 
to RR +++ 
From RR +++  
Duration [min] 
(mean interval) 
1.8 
(0 – 1.8) 
4.9 
(1.8 – 6.7) 
33.6 
(6.7 – 40.3) 
12.2 
(40.3 – 52.5) 
52.5 < 
Exposure 
through 
Whole 
body 
chamber 
Nose cone Nose cone - - 
MAP [mmHg] 
 
drop 
80 to 62 
fast drop 
62 to 27 
further drop 
27 to 17, x:̅ 19 
steep in-
crease 
17 to 52 
slight increase 
52 to physiologi-
cal 
HR [bpm] 
 
Slight 
drop 
327 to 
295 
Slight drop 
295 to 268 
further drop 
268 to 235 
steep in-
crease 
244 to 306 
drop 306 to physi-
ological (270) 
ReR [min-1]  
Arrhyth-
mic, pant-
ing 
drop 
92 to 77 
further drop 
77 to 30 
increase 
30 to 75 
75 to 
physiological 
BT [°C] 38.9 
early drop 
38.9 to 38.4 
drop 
38.4 to 36.0 
further drop 
36.0 to 35.6 
increase 
35.6 to 39.2 
Isoflurane [%] 
(min-max) 
x:̅ 4.4 
(4.1 - 4.6) 
Reduce individu-
ally,  
start from ~ 3.1 
Reduce individ-
ually, 
end ~ 2.4 
0 0 
Righting reflex +++  - - - -   +++ 
+++ 
(don’t test) 
Lid reflex untestable - - -   +++ +++ 
Ear reflex untestable - - -   +++ +++ 
Foot with-
drawal  
reflex (FWR) 
untestable ++/+  + 
+ or – 
(slow, weak) 
> +  +++ +++ 
Inguinal reflex 
(IR) 
untestable ++/+  + 
+ or – 
(slow, weak) 
> +  +++ +++ 
Muscle tone  
hind legs 
untestable ++/+  + - -   +++ +++ 
Excitation +++  - - - -  <++ < ++  - 
Cleaning +++ - - -   ++ + or ++ 
Tear produc-
tion / squinting 
+++ - - < ++ < + 
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Chewing/ 
mouthing 
- - - -  < +++ < ++ 
Shivering - - - -   +++ +++  - 
Bulbus rotation +++  - - - -   +++ +++ 
Defecation/ 
Urination 
+/ +++ - - ++/- Not specific 
Piloerection - - - -  < + +++  < - 
Respiratory 
sounds 
untestable - -   < +++ - - 
Symbols: - = no reaction/not present, + = minimal reaction, + = mild reaction, ++ = delayed/re-
duced/weaker reaction, +++ = physiological reaction. RR= righting reflex, FWR = foot withdrawal 
reflex, IR = inguinal reflex, MAP = mean arterial pressure, HR = heart rate, ReR = respiratory rate, 
BT = core body temperature. Atropine premedication (0.04 mg/kg) in the GP. 
(On the basis of the results from Publication 2, reflex definitions see there; parameter values are 
to be treated as reference values) 
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10.5 Typical MMF anaesthesia with AFN antagonisation 
Anaesthesia 
interval 
Induction 
Non- surgical 
tolerance 
Surgical  
tolerance 
Wake-up Recovery 
Definition 
MMF injec-
tion 
to RR - 
RR – 
to FWR/IR < + 
FWR/IR < + 
to AFN injec-
tion 
FWR/IR > + 
to RR +++ 
RR +++  
Duration 
[min] 
(mean inter-
val) 
3.5 
(0 – 3.5) 
5.7 
(3.5 – 9.2) 
31.5 
(9.2 – 40.6) 
7.6 
(40.6 – 48.2) 
48.2 < 
MAP [mmHg] 
slight drop 
75 to 56 
Stable 
56 to 62 
slight drop 
62 to 48 
Abrupt U-
shape 
48 over 22 to 
70 
decrease 
70 to physiological 
(57) 
HR [bpm] 
drop 
328 to 249 
slight drop 
249 to 225 
slight drop 
225 to 205 
steep increase 
205 to 334 
Slight increase  
drop 
334 to 358 to physio-
logical (270) 
ReR [min-1]  
slight drop 
94 to 73 
stable 
73 to 67 
stable 
67 to 65 
increase 
65 to 89 
89 to physiological 
BT [°C] 
 
early drop 
38.7 to 38.5 
slight drop 
38.5 to 38.0 
drop 
38.0 to 36.4 
further drop 
36.4 to 36.2 
increase 
36.2 to physiological 
Righting reflex +++  - - - -   +++ +++ 
Lid reflex +++  < + - - -   +++ +++ 
Ear reflex +++  < + +  < - + or - -   +++ +++ 
Foot with-
drawal reflex 
(FWR) 
+++  < ++ 
(only test if 
necessary) 
++  < - 
(sharp, quick) 
+ or – 
(sharp, quick) 
> +  +++ 
(only test if 
necessary) 
+++ 
(don’t test, only 
causes distress) 
Inguinal reflex 
(IR) 
+++  < ++ 
(only test if 
necessary) 
++  < - 
(sharp, quick) 
+ or – 
(sharp, quick) 
> +  +++ 
(only test if 
necessary) 
+++ 
(don’t test, only 
causes distress) 
Muscle tone 
hind legs 
+++  < + ++   - - -   +++ +++ 
Excitation < ++  - - - -  <+ < ++  - 
Chewing / 
mouthing 
< + - - -  < +++ < +++ 
Shivering - - - -   +++ +++  - 
Bulbus rota-
tion 
+++  - - - -   +++ +++ 
Piloerection < + - - -  < + +++  < - 
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Skin colour 
pink  
pink-red  
pink 
pink  pale 
pink 
pale pink 
pink-red  
pink 
pink 
Symbols: - = no reaction/not present, + = minimal reaction, + = mild reaction, ++ = delayed/re-
duced/weaker reaction, +++ = physiological reaction. RR= righting reflex, FWR = foot withdrawal 
reflex, IR = inguinal reflex, MAP = mean arterial pressure, HR = heart rate, ReR = respiratory rate, 
BT = core body temperature, AFN= atipamezole-flumazenil-naloxone antagonisation. 
(On the basis of the results from Publication 2, reflex definitions see there; parameter values are to 
be treated as reference values) 
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10.6 Typical KX anaesthesia with atipamezole antagonisation  
 
Anaesthesia 
Phase 
Induction 
Non- surgi-
cal toler-
ance 
Surgical toler-
ance 
Wake-up Recovery 
Definition 
KX injec-
tion to 
righting R - 
Righting R – 
to FWR/IR > 
+ 
FWR/IR < + 
to atipame-
zole injection 
Atipamezole 
injection to 
righting R +++ 
From RR +++  
Duration [min] 
(mean interval) 
2.6 
(0 – 2.6) 
3.4 
(2.6 – 6) 
34.6 
(6 – 40.6) 
59.7 
(40.6 – 100.3) 
100.3 < 
MAP [mmHg] 
 
slight 
drop, 
72 to 57 
stable, 
57 to 51 
slight rise  
51 to 60 
U trend, 
60 over 37 to 
54 
Stable 
Physiological 
(57)  
HR [bpm] 
 
slight drop 
270 to 232 
drop 
232 to 207 
slight drop, 
207 to 197 
Very slow in-
crease 
197 to 226  
Ongoing slow in-
crease to physio-
logical (260) 
RR [min-1]  
drop 
94 to 56 
stable 
56 
stable, 
56 
Slow increase 
56 to 65 
Slow increase to 
physiological 
BT [°C] 38.7 
early drop 
38.7 to 38.2 
drop 
38.2 to 37.3 
further drop 
37.3 to 36.4 
Very slow in-
crease 
36.4 to 38.3  
(after 5.5 h) 
Righting reflex +++  - - -  
-   +++ 
(unreliably 
+++) 
+++ 
(little move-
ment) 
Lid reflex +++  < - - - -   +++ +++ 
Ear reflex +++  < + +  < - + or - -   +++ +++ 
Foot with-
drawal reflex 
(FWR) 
 +++  < + 
(only test 
if neces-
sary) 
< +  < - + or - 
> +  +++ 
 
+++ 
(only test if nec-
essary) 
Inguinal reflex 
(IR) 
+++  < + 
(only test 
if neces-
sary) 
< +  < - + or - > +  +++ 
+++ 
(only test if nec-
essary) 
Muscle tone  
hind legs 
+++  < + < +   - + or - + or -  +++ +++ 
Excitation < +++  - - - -  <+++ < +++  - 
Chewing / 
mouthing 
< + - - -  +++ < +++ 
Shivering - - - -   +++ +++  - 
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Bulbus rotation +++  - - - -   +++ +++ 
Piloerection < + - < +++ < +++ +++  < - 
Sedation - - - <+++ +++  <+ 
Skin colour 
pink  
pink-red 
 pink 
pink  pale 
pink 
pale pink 
pink-red  
pink 
pink 
Symbols: - = no reaction/not present, + = minimal reaction, + = mild reaction, ++ = delayed/re-
duced/weaker reaction, +++ = physiological reaction, RR= righting reflex, FWR = foot withdrawal 
reflex, IR = inguinal reflex, MAP = mean arterial pressure, HR = heart rate, ReR = respiratory rate, 
BT = core body temperature. 
(On the basis of the results from Publication 2, reflex definitions see there; parameter values are to 
be treated as reference values) 
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11 Summary 
Anaesthesia in guinea pigs (GPs) has often been described as difficult and risky. Therefore, the 
included publications invested the effect of the mostly used anaesthesias MMF (medetomidine-
midazolam-fentanyl), isoflurane (Iso) and ketamine-xylazine (KX) on physiological parameters in 
GPs. Throughout the anaesthesia, the GPs’ cardiovascular parameters were monitored, using ab-
dominally implanted radiotelemetry devices to obtain optimal data quality. 
 
The surgical approach used for the implantation of the radiotelemetry transmitter is presented in 
detail in the first publication. For surgery, the GPs were anaesthetised with MMF (medetomidine-
midazolam-fentanyl) and they were antagonised with AFN (atipamezole-flumazenil-nalxone) at 
the end of the surgery. For pain medication, the GPs were started on meloxicam (0.4 mg/kg) and 
metamizole (80 mg/kg) 30 min before the surgery. Metamizole was continued for 24 h after sur-
gery and meloxicam for 2 more days. During the implantation, they were additionally covered with 
the fentanyl component in MMF. Prior to the surgery, enrofloxacin (10 mg/kg) was applied for 
antibiotic coverage which was continued for 2 more days. Using the implanted system, arterial 
blood pressure (BP), heart rate (HR) and core body temperature (BT) were measured throughout 
the first 24 h after the end of the implantation. The implantation approach led to the highest long-
term survival rate reported to date, with 13 of 16 GPs (81 %) surviving. The GPs lost body weight 
(BW) until 2 d after surgery (-11.9 %, -53.6 g) but steadily increased their weight thereafter. The 
GPs had returned to physiological values in BP and BT at 8 h after abdominal surgery and at 24 h 
regarding HR. As GPs are stress-prone, recommendations for stress reduced handling were given 
for before, during and after the implantation. The findings on the effects of the implantation can 
be used as a model for other abdominal operations in the GP. 
 
The second publication described the investigation of the effects of one-time Iso, MMF and KX 
anaesthesia on the physiological parameters using the 13 implanted GPs. Each animal was anes-
thetised once with MMF, Iso and KX at an interval of 7 d. The entire anaesthesia pass was recorded 
radiotelemetrically and supplemented by manual measurements of respiratory rate (ReR), re-
flexes and blood glucose (BG). One anaesthesia pass included 120 min acclimatization time, of 
which the last 15 min were averaged as individual baseline values. The GPs were then premedi-
cated; with Iso with atropine and with MMF and KX with sodium chloride as placebo. Ten minutes 
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later, anaesthesia was initiated, for Iso anaesthesia using a pre-filled whole body chamber and for 
MMF and KX with intramuscular injections into the hind limbs. Anaesthesia was discontinued after 
40 min by Iso supply stop, AFN antagonisation for MMF or partial antagonisation with atipamezole 
for KX anaesthesia. The MAP, HR, BT were measured continuously until at least 240 min after 
anaesthesia induction. Respiratory rate (ReR) was measured until at least 55 min and reflexes were 
tested until the GPs showed a positive righting reflex again. BG values were measured at 7.5, 20 
and 40 min during anaesthesia. 
With Iso use, all GPs reached a surgical tolerance, 11 did so with MMF anaesthesia and only 7 
reached an operable state with KX. The induction, non-surgical tolerance and surgical tolerance 
phase durations did not differ considerably between the 3 anaesthetics. Following MMF and Iso 
there were short wake-up times (7.6 & 12.2 min), whereas it required 59.7 min until the GPs re-
gained their RR after KX. MMF anaesthesia led to a marked transient MAP decrease after antago-
nisation, otherwise the MAP and the HR were only mildly altered. Iso exposure led to a marked 
hypotension during anaesthesia maintenance (approx. 20 mmHg) and the HR was only mildly in-
creased at the beginning of the anaesthesia. KX caused mild deviations from the normal physiology 
for MAP and HR during maintenance. However, after partial antagonisation, the MAP dropped and 
the GPs recovered only slowly. The HR was also reduced and increased only gradually during the 
wake-up following KX anaesthesia. 
All anaesthetics induced hypothermia, but the animals lost the most BT with Iso anaesthesia. Im-
mediately after the end of the MMF and Iso anaesthesia, the GPs were able to quickly lift their BT 
back to the starting level through shivering. After KX anaesthesia only 3 of the 7 GPs had returned 
to 38.8°C after 5 h, the other 4 still had not reached pre-anaesthetic BT values after 8 h. Respira-
tory depression occurred with all 3 anaesthetics, with KX leading to a moderate (-52%) and Iso to 
a severe (-71%) hypoventilation. There was also a strong irritation of the mucous membranes of 
the respiratory tract through the respiratory gas. Subsequent mucosal secretion could only be 
alleviated by atropine pre-medication in the short term. BG increases were observed during KX 
(moderate) and strongly during MMF anaesthesia. The reflex responses varied considerably be-
tween the anaesthetics. They were strong and quick during MMF anaesthesia and slightly less so 
with KX use. Iso exposure led to weak and slow reflex responses. Overall, MMF was determined 
to be the anaesthesia of choice; Iso can only be advised for short and non-painful procedures and 
we advise against the use of KX anaesthesia in GPs. 
11 Summary 
128 
 
After investigating the effects of single anaesthesia with Iso, MMF and KX, the third paper de-
scribed the impact of repeated MMF and Iso anaesthesia. KX was not tested for anaesthesia rep-
etition because of its highly unfavourable effects in the recovery phase. Twelve instrumented MS 
were anesthetised in 2 anaesthesia sets, 6 times over 3 weeks with either only Iso or only MMF. 
Each anaesthesia repetition was performed as described for the single anaesthesia.  
All GPs reached a surgical tolerance and this could be maintained for the desired 40 min. Overall, 
the anaesthetic profiles of MMF and Iso did not change greatly with anaesthesia repetition.  
During Iso exposure, the repeated atropine premedication caused the HR to increase, and this 
increase remained longer with progressing repetitions. During MMF the wake-up phase shortened 
from the 1st to the 2nd repetition and the MAP and the HR decreased from the first to all following 
anaesthesias. During the MMF maintenance, there was a large individual variation in the BP be-
tween the GPs, but the single animal always exhibited similar MAP values during all of the repeti-
tions. At 40 min of the MMF anaesthesia, the BG had increased particularly strongly in those an-
aesthesias that were performed with an interval of 2 d.  
The BT decrease and the BW increase were not altered. Both anaesthetics can therefore be used 
repeatedly in the GP with very little change in the anaesthesia profile compared to the single an-
aesthesias. The GPs developed increasingly stronger defensive reactions which were particularly 
pronounced with Iso. They reduced the reliability with which the injections of MMF and atropine 
could be performed and with that the induction of anaesthesia. Although repeated Iso anaesthesia 
led to lesser repetition-related effects, the highly disadvantageous effects of hypotension, mucous 
production and hypoventilation with Iso anaesthesia remained and were further worsened by the 
strong defensive reactions. MMF led to a much more beneficial anaesthesia with the only draw-
back of altering the BG and the occurring hypothermia. In conclusion, MMF is superior for both 
single and repeated anaesthesia use in the GP. Iso is only preferable to MMF, if multiple anaes-
thesias need to be performed on the same day.  
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12 Zusammenfassung 
Die Anästhesie an Meerschweinchen (MS) wurde schon oft als schwierig und risikoreich beschrie-
ben. Mit diesem Hintergrund wurden die drei häufigsten Narkosemittel, Medetomidin-Mida-
zolam-Fentanyl (MMF), Isofluran (Iso) und Ketamin-Xylazin (KX), hinsichtlich ihres Einflusses auf 
die physiologischen Parameter im MS untersucht. Die Überwachung vor, während und nach den 
Anästhesien wurde durch einen abdominal implantierten Radiotelemetriesender durchgeführt. 
In der ersten Publikation wurde die Implantation des Telemetriesenders detailliert dargestellt. Für 
den Eingriff wurden die MS mit MMF anästhesiert und die Narkose wurde am Ende des Eingriffes 
mit AFN (Atipamezol- Flumazenil-Naloxon) wieder aufgehoben. Die Analgesie bestand aus Melo-
xicam (0,4 mg/kg) und Metamizol (80 mg/kg), womit 30 Minuten vor dem Start der Operation 
begonnen wurde. Während der Anästhesie wurde die Analgesie zusätzlich über die Fentanyl Kom-
ponente des MMFs erhalten. Nach der Implantation wurde Metamizol für 24 Stunden und Melo-
xicam für 48 h fortgesetzt. Zur antibiotischen Versorgung erhielten die MS Enrofloxacin (10 mg/kg) 
vor dem Beginn der Operation und in den zwei darauffolgenden Tagen. Unter Verwendung des 
implantierten Senders wurden der arterielle Blutdruck (BD), die Herzfrequenz (HF) und die Kern-
körpertemperatur (KT) in den ersten 24 h nach dem Ende der Implantation gemessen. Die durch-
geführte Implantationsherangehensweise führte zu der bisher höchsten publizierten Langzeit-
überlebensrate mit 13 von 16 Tieren (81%). Bis 2 Tage nach der Operation verloren die Tiere an 
Körpergewicht (-11,9 %, -53,6 g). Danach stieg ihr Gewicht jedoch stetig wieder an. Die MS waren 
nach 8 h nach ihrer abdominalen Operation zu physiologischen Werten in Blutdruck und Körper-
kerntemperatur und nach 24 h zu normalen HF zurückgekehrt. Aufgrund der hohen Stressanfäl-
ligkeit von MS, wurden Empfehlungen für stressarmes Handling, für vor, während und nach der 
Implantation gegeben. Die Erkenntnisse über die Auswirkungen der Implantation können model-
haft auf andere Bauchoperationen im MS angewendet werden. 
Die zweite Veröffentlichung beschrieb die Untersuchung der Wirkungen von einmaligen Iso, MMF 
und KX Anästhesien auf die physiologischen Parameter unter Verwendung der 13 implantierten 
MS. Jedes Tier wurde einmalig mit MMF, Iso und KX im Abstand von 7 d anästhesiert. Der gesamte 
Anästhesiedurchgang wurde radiotelemetrisch aufgezeichnet und durch manuelle Erhebungen 
für Atemfrequenz (AF), Reflexe und Blutglukose (BG) ergänzt. Ein Anästhesiedurchgang beinhal-
tete 120 min Akklimatisierungszeit, wovon die letzten 15 min als individuelle Baselinewerte gemit-
telt wurden. Danach wurden die MS prämediziert; bei Iso mit Atropin und bei MMF und KX mit 
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Natriumchlorid als Placebo. Zehn min später wurde die Anästhesie eingeleitet mit einer vorgeflu-
teten Ganzkörperkammer für die Iso Anästhesie und für MMF und KX mit intramuskulären Injek-
tionen in die Hintergliedmaßen. Die Anästhesie wurde für nach 40 min aufgehoben durch Iso-zu-
fuhrstopp, AFN Antagonisierung oder Teilantagonisierung mit Atipamezol. Der BD, die HF, und die 
KT wurden kontinuierlich bis mindestens 240 min nach Anästhesieeinleitung gemessen. Die AF 
wurde bis mindestens 55 min gemessen, und die Reflexe wurden bis zum Erreichen eines positiven 
Stellreflexes getestet. Bei 7,5, 20 und 40 min während der Anästhesie wurden BG Werte erhoben.  
 
Mit der Anwendung von Iso erreichten alle MS eine chirurgische Toleranz, mit der MMF-Anästhe-
sie waren es 11 MS und nur 7 erreichten einen operablen Zustand mit KX. Die Induktion, nicht-
chirurgische Toleranz und chirurgische Toleranzphasendauer unterschieden sich nicht erheblich 
zwischen den 3 Anästhetika. Auf die Narkosen mit MMF und Iso folgten kurze Weckzeiten (7,6 & 
12,2 min), während es 59,7 min benötigte, bis die MS ihren RR nach KX wiedererlangten. Die MMF-
Anästhesie führte zu einer kurzen, deutlichen BD-Abnahme nach Antagonisierung, ansonsten wur-
den der BD und der HF nur geringfügig verändert. Die Iso-Exposition führte zu einer ausgeprägten 
Hypotonie während der Anästhesieerhaltung (ca. 20 mmHg) und die HF war zu Beginn der Anäs-
thesie nur leicht erhöht. KX verursachte nur milde Abweichungen von der normalen Physiologie 
für BD und HF während der Anästhesieerhaltung. Nach der Teilantagonisierung fiel der BD die HF 
und die KT jedoch ab und die MS erholten sich nur langsam.  
Alle Anästhetika induzierten eine Hypothermie, aber unter der Iso Narkose verloren die MS am 
schnellsten und am meisten Körpertemperatur. Direkt nach dem Ende der MMF- und Iso-Narkose 
konnten sie ihre KT über Kältezittern schnell wieder auf das Ausgangslevel heben. Nach der KX-
Anästhesie waren jedoch nur 3 der 7 GPs auf 38,8 ° C KT zurückgekehrt, die anderen 4 hatten auch 
nach 8 h noch nicht wieder ihre Ausgangskörperkerntemperatur erreicht. Eine Atemdepression 
trat bei allen 3 Narkosemitteln auf, am ausgeprägtesten jedoch unter der Iso-Narkose (-71%). Dort 
trat zusätzlich eine starke Reizung der Schleimhäute der Atemwege durch das Atemgas auf. Die 
nachfolgende Schleimsekretion konnte durch die Atropinprämedikation nur kurzfristig gelindert 
werden. Der BG-Spiegel stieg während der Anästhesie mit KX (mäßig) und während der MMF-
Anästhesie stark an. Die Reflexantworten variierten erheblich zwischen den Anästhetika. Sie wa-
ren stark und schnell während der MMF Anästhesie und etwas weniger deutlich ausgeprägt unter 
der KX-Anwendung. Die Iso-Exposition führte hingegen zu schwachen und langsamen Reflexant-
worten. Insgesamt ist MMF die Anästhesie der Wahl beim MS; Iso sollte nur für kurze und nicht 
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schmerzhafte Verfahren beraten werden und wir empfehlen die Verwendung von KX Anästhesie 
bei GPs. 
Nach der Untersuchung der Einzelanästhesieffekte mit Iso, MMF und KX, beschrieb die dritte Pub-
likation die Auswirkungen der wiederholten MMF- und Iso-Anästhesie. Aufgrund der deutlichen 
Nachtteile der KX-Narkose in der Aufwachphase wurde KX von der Wiederholungsstudie ausge-
schlossen. Zwölf instrumentierte MS wurden in 2 Anästhesiesets jeweils 6 mal über 3 Wochen mit 
entweder nur Iso oder nur MMF anästhesiert. Der Aufbau der einzelnen Anästhesiedurchgänge 
war derselbe wie bei in Einzelanästhesien beschrieben. Alle GPs erreichten eine chirurgische To-
leranz, und diese konnte für die gewünschten 40 min aufrechterhalten werden. Insgesamt änder-
ten sich die Anästhesieprofile von MMF und Iso nur sehr gering im Verlauf der Anästhesiewieder-
holung. Durch die wiederholte Atropinprämedikation nahm die HF zu und dieser Anstieg blieb mit 
fortschreitenden Wiederholungen immer länger bestehen. Bei der MMF Anästhesie verkürzte sich 
die Aufwachzeit vor allem von der 1. auf die 2. Wiederholung. Der BP und die HF nahmen nach 
der ersten Wiederholung für die nachfolgenden Anästhesien ab. Während der MMF-Anästhesie-
erhaltung zeigten die MS große individuelle Variationen im BD. Jedes einzelne Tier blieb jedoch 
während allen Wiederholungen auf seinem eigenen Niveau. Die BG war bei den MMF-Anästhesien 
zwischen denen nur 2 Tage lagen 40 min nach der Anästhesieeinleitung besonders hoch. Die KT-
Abnahme trat sowohl bei MMF, als auch bei Iso während der Anästhesie auf und die Körperge-
wichtsentwicklung veränderte sich durch die Wiederholungen nicht.  
Sowohl Iso als auch MMF können nach diesen Ergebnissen daher wiederholt in MS eingesetzt 
werden. Trotzdem entwickelten die MS zunehmend stärkere Abwehrreaktionen gegen die Anäs-
thesieeinleitung, die bei Iso besonders ausgeprägt waren. Sie reduzierten die Zuverlässigkeit, mit 
der die Injektionen von MMF und Atropin durchgeführt werden konnten und damit die Induktion 
der Anästhesie. Die Iso-Anästhesie führte zwar zu geringeren Wiederholungswirkungen im Ver-
gleich zu MMF, das Anästhesieprofil mit der starken Atemdepression und Schleimproduktion und 
der starken Hypotension bestand jedoch weiterhin. Insgesamt sind die Effekte der Wiederholun-
gen bei der MMF Anästhesie weitgehend vernachlässigbar und das Anästhesieprofil ist wesentlich 
vorteilhafter für die MS. Daher ist MMF für die einfache und wiederholte Anästhesie im MS das 
Anästhetikum der Wahl, es sei denn am selben Tag müssen mehrere Anästhesien durchgeführt 
werden müssen. In dem Fall ist Iso vorzuziehen.  
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